1. SMRC Oncology. N. N. Blokhin (Moscow, Russian Federation)

Keywords:colorectal cancer (CRC), gear education, endoscopy, diagnostics, gear the path of development of CRC

Abstract:In recent years, there has been a trend towards a steady increase in the incidence of colorectal cancer (CRC): the increase in the absolute number of patients with colon cancer from 2009 to 2015 amounted to 11.3%; rectal cancer - 9.9%. In the structure of mortality from malignant tumors of the KRR in our country takes the second place, second only to lung cancer. This fact is due to the fact, that the primary treatment of patients to the doctor advanced forms of cancer (III-IV stage) are diagnosed in 71.4% of patients with colon cancer and 62.4% in cases of rectal cancer. Such a late diagnosis is primarily due to the lack of an appropriate Federal screening program, as well as to the lack of awareness of medical workers in modern ideas about colonic carcinogenesis and precancerous changes in the mucous membrane of the colon.

• References total 45 ⇓ :: .
  1. Seigel R., Naishadham D., Jemal A. «Cancer Statistics, 2013» // CA cancer j. clin. - 2013 - Vol. - 63 - P. 11-30
  2. Pathology and Genetics of Tumours of the Digestive System (IARC WHO Classification of Tumours)// World Health Organization; (October 2010)
  3. Davidov M. I., Aksel E. M. Journal of Russian Cancer Research Center named N. N. Blokhin, 2011, t. 22, № 3 (85) (suppl. 1)
  4. Zaridze D. G. Cancer prevention // IMA press – Moscow – 2009.
  5. Fearon E. R. Vogelstein B. A genetic model for colorectal tumorigenesis // Cell - 1990 - Vol. 61 - P. 759-767.
  6. American Cancer Society. Cancer facts and figures 2011-2013// Atlanta (Ga): American Cancer Society - 2011.
  7. Ferlay J., Shin H. R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008 // Int. J. Cancer 2010 - Vol. 127 - P. 2893-2917.
  8. Jass J. R. Large intestine. Histological typing of intestinal tumours // In: Jass J.R, Sobin L.H, editors. World Health Organization international histological classification of tumours, 2nd ed. Berlin: Springer-Verlag - 1989 - P. 30.
  9. Muto T., Bussey H. J.R., Morson B. C. M. The evolution of cancer of the colon and rectum // Cancer - 1975 - Vol. 36 - P. 2251-2270.
  10. Jass J. R. Relation between metaplastic polyp and carcinoma of the colorectum // Lancet - 1983 - Vol. 1 - P. 28-30.
  11. Jass J. R., Young J., Leggett B. A. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum // Histopathology - 2000 - Vol.37 - P. 295-301.
  12. Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features // Histopathology - 2007 - Vol. 50 - P. 113-130.
  13. Leggett B. A., Devereaux B., Biden K. et al. Hyperplastic polyposis: association with colorectal cancer // Am. J. Surg. Pathol. - 2001 - Vol. 25 - P. 177-184.
  14. Orlowska J. Serrated lesions and hyperplastic (serrated) polyposis relationship with colorectal cancer: classification and surveillance recommendations // Gastrointestinal Endoscopy - 2013 - Vol. 77 - P. 6.
  15. Longacre T. A., Fenoglio-Preiser C. M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia // Am. J. Surg. Pathol. - 1990 - Vol. 14 - P. 524-537.
  16. Matsumoto T., Mizuno M., Shimizu M. et al. Serrated adenoma of the colorectum: colonoscopic and histologic features // Gastrointest. Endosc. - 1999 - Vol. 49 - P. 732-742.
  17. Bariol C., Hawkins N. J., Turner J. J. et al. Histopathological and clinical evaluation of serrated adenomas of the colon and rectum // Mod. Pathol. - 2003 - Vol. 16 - P. 417-423.
  18. Jass J. R. Hyperplastic polyps and serrated adenomas of the colorectum // Histopathology - 2002 - Vol. 41(Suppl 2) - P. 367-371.
  19. Rex D. K., Ahnen D. J., Baron J. A. et al. Serrated lesions of the colorectum: review and recommendations from an expert panel // Am. J. Gastroenterol. - 2012 - Vol. 107 - P. 1315-1328.
  20. Jass J. R. Serrated adenoma of the colorectum // Curr. Diagn. Pathol. - 2002 - Vol. 8 - P. 42-49.
  21. Iwabuchi M., Sasano H., Hiwatashi N. et al. Serrated adenoma: a clinicopathological, DNA ploidy and immunohistochemical study // Anticancer Res. - 2000 - Vol. 20 - P. 1141-1147.
  22. Snover D. C. Update on the serrated pathway to colorectal carcinoma // Hum. Pathol. - 2011 - Vol. 42 - P. 1-10.
  23. Wallace M., Kiesslich R. Advances in endoscopic imaging of colorectal Neoplasia // Gastroenterology - 2010 - Vol. 138 - P. 2140-2150.
  24. Kimura T., Yamamoto E., Yamano H. et. al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma // Am. J. Gastroenterol. - 2012 - Vol. 107 - P. 460-469.
  25. Torlakovic E., Skovland E., Snover D. C. et al. Morphologic reappraisal of serrated colorectal polyps // Am. J. Surg. Pathol. - 2003 - Vol. 27 - P. 65-81.
  26. Berkeley N., Dora Lam-Himlin, Arnold M. A. et al. The cutting edge of serrated polyps: a practical guide to approaching and managing serrated colon polyps // Gastrointest. Endosc. - 2013 - Vol. 77 - P. 3.
  27. Rex D.K, Ahnen D. J., Baron J. A. et al. Serrated lesions of the colorectum: review and recommendations from an expert panel // Am. J. Gastroenterol. - 2012 - Vol. 107 - P. 1315-29, quiz 1314.
  28. Kudo S., Tamura S., Nakajima T. et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy // Gastrointest. Endosc. - 1996 - Vol. 44 - P. 8-14.
  29. S. Kudo, R. Lambert, Allen J. I. et al. Nonpolypoid neoplastic lesions of the colorectal mucosa // Gastrointest. Endosc. - 2008 - Vol. 68 - P. 4.
  30. Hetzel J. T., Huang C. S., Coukos J. A. et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort // Am. J. Gastroenterol. - 2010 - Vol. 105 - P. 2656-2664.
  31. Sano Y., Tanaka S., Kudo S. E., Saito S. et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team // Dig. Endosc. - 2016 - Vol. 28 (5) - P. 526-33
  32. Tadepalli U. S., Feihel D., Miller K. M. et al. Amorphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video) // Gastrointest. Endosc. - 2011 - Vol. 74 - P. 1360-368.
  33. Lu F. I., van Niekerk de W., Owen D. et al. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma // Am. J. Surg. Pathol. - 2010 - Vol. 34 - P. 927-934.
  34. Hazewinkel Y., Lopez-Ceron M., East J. E. et al. Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging // Gastrointest. Endosc. - 2013 - Vol. 77 - P. 916-924.
  35. Oka S., Tanaka S., Hiyama T. et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types // Gastrointest. Endosc. - 2004 - Vol. 59 - P. 213-219.
  36. Kim K. M., Lee E. J. Kras mutations in traditional serrated adenomas from Korea herald an aggressive phenotype // Am. J. Surg. Pathol. - 2010 - Vol. 34 - P. 667-675.
  37. Hassan С., Quintero E., Dumonceau J. M. et al. Post-polypectomy colonoscopy surveillance: European Society of gastrointestinal Endoscopy (ESGE) Guideline // Endoscopy - 2013 - Vol. 45 - P. 841-851.
  38. Fedyanin M. Yu., Tryakin A. A., Tjulandin S. A. Role of microsatellite instability in colon cancer. Oncological Coloproctology, 2009, vol. 3–12, pp.19–26
  39. Ogino S., Nosho K., Kirkner G. J. et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut, 2009; Vol. 58, рр. 90-6.
  40. Vasen H. F., Möslein G., Alonso A. et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet, 2007, Vol. 44(6), рр. 353-62.
  41. Peltomäki P. Lynch syndrome genes. Fam Cancer, 2005, Vol. 4(3), рр. 227‒32.
  42. Warusavitarne J., Schnitzler M. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis, 2007, Vol. 22(7), рр. 739-48.
  43. Uraoka T, Saito Y, Ikematsu H, Yamamoto K, Sano Y. Sano’s capillary pattern classification for narrow-band imaging of early colorectal lesions. Dig Endosc. 2011; 23 Suppl 1:112-5, pp. 1443-1661.
  44. A. M. Nechipay, M. V. Zobnina, L. M. Cherkasova, I. B. Perfilyev, V. A. Krivopuskov. Morphological and endoscopic diagnostic criteria of serrated adenomas of the colon. Ross z gastroenterol gepatol koloproktol 2016; 26(2):107–115
  45. Muto T., Bussey H. J.R., Morson B. C.M. The evolution of cancer of the colon and rectum // Cancer - 1975 - Vol. 36 - P. 2251-2270

Full text is published :
Zobnina, M. V. Karasev, I.A., Cherkes L. V., Tumanyan A. O. et al. THE SERRATED NEOPLASMS OF THE COLON: ENDOSCOPIC DIAGNOSIS, THE ROLE IN COLORECTAL CARCINOGENESIS. Experimental and Clinical Gastroenterology Journal. 2018;152(04):04-08
Read & Download full text

1. Branch of the Federal State Budget Scientific Institution “The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences” (Novosibirsk, Russian Federation)
2. Federal State Budget Educational Institution of Higher Education “Novosibirsk State Medical University” Ministry of Health of the Russian Federation (Novosibirsk, Russian Federation)
3. Cancer Research Institute, Tomsk National Research Medical Centre RAS (Tomsk, Russian Federation)
4. Tomsk State University (Tomsk, Russian Federation)
5. Non-State Healthcare Institution «Road Clinical Hospital on Novosibirsk-Main station» of Russian Railways Joint stock company (Novosibirsk, Russian Federation)

Keywords:gastric cancer, polymorphism, rs1800795, rs16944, IL6, IL1B, pepsinogenes, H. pylori

Abstract:Background: Genetic polymorphism of some inflammatory cytokines is associated with the risk of developing specific, H. pylori-associated diseases, including gastric cancer (GC). Aim: To study the genotypes and alleles frequencies of polymorphism 174G / C (rs1800795) of the IL6 gene and polymorphism -511C / T (rs16944) of the IL1B gene, as well as their association with biomarkers of atrophy in patients with GC in the clinical «case-control» study. Materials and methods: 80 patients with GC (45 mails and 35 females with an average age of 61.0 ± 13.4 years) from two medical centers were studied. In the control, DNA samples from 87 subjects were matched by sex and age from the base of the multicenter cohort study HAPIEE. DNA was isolated from venous blood using phenol-chloroform extraction. DNA samples were genotyped according to published methods. Serum samples were tested using a diagnostic kit for enzyme-linked immunosorbent assays to determine the levels of pepsinogen I (PGI), PGII, PGI/PGII ratios, gastrin-17 and IgG antibodies to H. pylori. Results: In the general group, association of polymorphisms of 174 G/C of the IL6 gene and the -511C/T gene of the IL1B gene with the GC was not found. However, in women, the frequency of the G/G genotype of the IL6 gene was 2 times higher in the group with G/C than in the control (p=0.03). In patients with corpus atrophy, the G/G genotype was revealed twice as often as homozygous C/C variant of the IL6 gene (p=0.002). In patients with GC, the genotype with a rare T allele (C/T + T/T) of the IL1B gene was significantly more frequent than the common homozygous C/C variant (p=0.03). The rare homozygous T/T genotype was significantly less frequent in patients with GC and no signs of corpus atrophy (PGI >30 μg/l): 11.3% vs 47.2% (C/T genotype) and vs 41.5% (genotype C/C) (p <0.001). Conclusions: The received data allow assuming the possible connection of studied polymorphisms with the formation of a cancer phenotype of the gastritis, which requires further study of their significance (weight) in the GC riskometry.

• References total 37 ⇓ :: .
  1. Crew K. D., Neugut A. I. Epidemiology of gastric cancer. World J Gastroenterol, 2006, vol. 12(3), pp. 354-362.
  2. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin, 2002, vol. 52, pp. 23-47.
  3. Davydovа М. I., Аksel’ Е. М. Statistics of malignant tumors in Russia and CIS countries in 2012. Мoscow: Izdatel’skaya gruppa RONTS, 2014. 226 p.
  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 1992, vol. 52(24), pp. 6735-40.
  5. Schlemper R. J., Riddell R. H., Kato Y., Borchard F. et al. The Vienna classifcation of gastrointestinal epithelial neoplasia. Gut, 2000, vol. 47(2), pp. 251-5.
  6. Parkin D. M. International variation. Oncogene, 2004, vol. 23, pp. 6329-40.
  7. Agréus L., Kuipers E.J, Kupcinskas L., Malfertheiner P. et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol, 2012, vol. 47(2), pp. 136-147.
  8. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer, 2006, vol.9, pp. 245-253.
  9. Yamaoka Y., Kita M., Kodama T., Sawai N., Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology, 1996, vol. 110, pp. 1744-52.
  10. McColl K.E., El-Omar E., Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am, 2000, vol. 29, pp. 687-703.
  11. Lowry S. F. Cytokine mediators of immunity and inflammation. Arch Surg, 1993, vol. 128, pp. 1235-1241.
  12. Romano M., Sironi M., Toniatti C., Polentarutti N. et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity.1997, vol. 6, pp. 315-325.
  13. Chi L. J., Lu H. T., Li G. L., Wang X. M. et al. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol, 2010, vol. 161, pp. 480-489.
  14. Ray A., LaForge K.S. and Sehgal P. B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol, 1990, vol. 10, pp. 5736-5746.
  15. Du Y., Gao L., Zhang K., Wang J. Association of the IL6 polymorphism rs1800796 with cancer risk: a meta-analysis. Genetics and Molecular Research, 2015, vol. 14(4), pp. 13236-13246.
  16. Juni W., Wenjun H., Jinxin L., Legen N. et al. Association of IL-6 polymorphisms with gastric cancer risk: evidences from a meta-analysis. Cytokine, 2012, vol. 59(1), pp. 176-83.
  17. Mayev I. V., Kucheryavy Yu.A., Oganesyan T. S. Interleukin-1β allelic polymorphism at H. pylori infection. RJGHC. 2008. Vol.18. No5. P. 4–11.
  18. Schepp W., Dehne K., Herrmuth H. et al. Identification and functional importance of IL-1 receptors on rat parietal cells. Am J Physiol, 1998, vol. 275, pp. 1094-1105.
  19. Hitzler I., Sayi A., Kohler E., Engler D. B. et al. Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1β and IL-18. J Immunol, 2012, vol. 188(8), pp. 3594-3602.
  20. Berezhnaya N. M. The role of immune cells in the tumor microenvironment: The interaction of cells of the immune system with the other components of the microenvironment. Oncology 2009; 11 (2): 86-93.
  21. Macri A., Versaci A., Loddo S., Scuderi G. et al. Serum levels of interleukin-1 beta, interleukin-8 and tumor necrosis factor alpha as markers of gastric cancer. Biomarcers, 2006, vol. 11(2), pp. 184-193.
  22. Gonzalez C.A, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer, 2004, vol. 100, pp. 249-260.
  23. El-Omar E.M., Carrington M., Chow W. H. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 2000, vol. 404, pp. 398-402.
  24. Jyh-Ming Liou et al. IL-1β-511 polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese. Helicobacter, 2007, vol. 12, pp. 142-149.
  25. Machado J. C., Pharoah P., Sousa S. Interleukin-1β and interleukin-1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology, 2001, vol. 121(4), pp. 823-829.
  26. Rad R., Dossumbekova A., Neu B. et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut, 2004, vol. 53, pp. 1082-1089.
  27. Farin Kamangar et al. Polymorphisms in inflammation related genes and risk of gastric cancer (Finland). Cancer Causes Control, 2006, vol. 17, pp. 117-125.
  28. Matsukura N., Yamada S., Kato S. et al. Genetic differences in interleukin-1β polymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res, 2003, vol. 22, pp. 47-55.
  29. Manniatis T, Fritsch E.F, Sambrook J. Molecular cloning: A laboratory manual. Cold spring harbor, New York, 1982.
  30. Zhang D. et al. Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer, 2007, vol. 7, pp. 45.
  31. Bartchewsky W. Jr., Martini M. R., Masiero M., Squassoni A. C., Alvarez M. C., Ladeira M. S., Salvatore D., Trevisan M., Pedrazzoli J. Jr. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX- 2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol, 2009, vol. 44 (2), pp. 153-161.
  32. Bennermo M., Held C., Stemme S., Ericsson C. G. et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem, 2004, vol. 50(11), pp. 2136-40.
  33. Hwang I. R., Hsu P. I., Peterson L. E., Gutierrez O. et al. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori associated gastroduodenal diseases. Helicobacter, 2003, vol. 8, pp. 142-8.
  34. Pohjanen V. M., Koivurova O. P., Mäkinen J. M., Karhukorpi J. M. et al. Interleukin 6 gene polymorphism -174 is associated with the diffuse type gastric carcinoma, 2013, vol. 52(10), pp. 976-82.
  35. He C, Tu H, Sun L. et al. Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese. Carcinogenesis, 2013, vol. 34, pp. 1450-7.
  36. El-Omar E.M, Carrington M., Chow W. H., McColl K.E. et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature, 2001, vol. 5, pp. 6842-99.
  37. Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 2015, vol. 64 (9), pp.1353-1367.

Full text is published :
Belkovets A.V., Kurilovich S.A., Maksimov V.N., Ragino Y.I., et al. POLYMORPHISM OF THE GENES OF INFLAMMATORY CYTOKINES IL6 AND IL1B IN PATIENTS WITH GASTRIC CANCER IN A CLINICAL CASE-CONTROL STUDY. Experimental and Clinical Gastroenterology Journal. 2018;152(04):09-17
Read & Download full text

1. Moscow Clinical Research and Practical Center, named after A. S. Loginov Moscow Healthcare Department (Moscow, Russian Federation)

Keywords:transient fibroelastometry of the liver, M-sensor, XL-sensor, liver fibrosis, non-alcoholic fatty liver disease, body mass index

Abstract:The purpose of the study: to evaluate the effectiveness of the use of transient liver fibroelastometry (TLF) in the determination of the stage of liver fibrosis (LF) in patients with non-alcoholic fatty liver disease (NAFLD) and obesity using XL- and M-sensors. Materials and methods: 110 patients with NAFLD were examined at different stages of the disease at the age of 29 to 82 years. The average BMI is 30.35 ± 5.35. The diagnosis is based on standard laboratory and instrumental data, assessment of the degree of steatosis depending on the stage of ultrasound and liver fibrosis on device for noninvasive determination of the degree of liver fibrosis and using XL and M sensors, using a puncture liver biopsy. Results: In patients with NAFLD and BMI more than 31.5 kg / cm2, when performing an M-sensor study, the number of studies with IqR> 30% (with low reliability) was more than 80%. In patients with NAFLD and BMI more than 31.5 kg / cm² when performing an XL-sensor, the number of studies with IqR> 30% was 4%. The sensitivity of the method ranges from 0.73 at the stage of F 2-3 on the METAVIR scale and 0.89 at F4, the specificity from 0.7 at F2-3 to 0.77 at F4. AUROC as a whole 0,8 that speaks about good reliability of a method. Conclusions: patients with NAFLD and BMI 30.35 ± 5.36 recommended to perform TLF using an XL-sensor. A BMI of 39 kg / m² or more is an absolute limitation for performing TLF.

• References total 14 ⇓ :: .
  1. Wong R.J, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2017 Nov;46 (10):974-980. https://doi.org/10.1111/apt.14327
  2. Rich N.E, Oji S, Mufti A.R, Browning J.D, Parikh N.D, Odewole M., Mayo H., Singal A.G. Racial and Ethnic Disparities in Non-alcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Sep 29. pii: S1542-3565 https://doi.org/10.1016/j.cgh.2017.09.041
  3. Drapkina O. M., Smirin V. I., Ivashkin V. T. NAFLD: modern insight of the issue. Lechashchy vrach, 2010; 5(5):57–61 (In Russ.)
  4. V. T. Ivashkin, O. M. Drapkina, I. V. Mayev, A. S. Trukhmanov, D. V. Blinov, L. K. Palgova, V. V. Tsukanov, T. I. Ushakova. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Ross z gastroenterol gepatol koloproktol 2016; 25(6):31–41
  5. Rinella M. E. Nonalcoholic fatty liver disease: a systematic review.// JAMA 2015. V.313. P. 2263-2273. https://doi.org/10.1001/jama.2015.5370
  6. Bakulin I. G., Sandler Yu.G., Vinnitskaya E.V, Keyan V. A., Rodionova S. V., Rotin D. L. Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency. Therapeutic archive 2017;89(2):59–65.
  7. Wong V.W, Wong G.L, Choi P.C, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.// Gut 2010;59:969-74. http://doi/10.1002/hep4.1134/full
  8. Ascha M.S., Hanouneh I. A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. // Hepatology 2010; 51: 1972-8. https://dx.doi.org/10.4254%2Fwjh.v9.i7.385
  9. Bhala N., Angulo P., van der Poorten D., et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011;54:1208-16. https://doi.org/10.1002/hep.24491
  10. Younossi Z.M., Otgonsuren M., Henry L., Venkatesan C., Mishra A., Erario M., Hunt S. Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States from 2004-2009. Hepatology 2015 Aug 14. http://doi.org/10.1002/hep.28123
  11. David Sherman; Phillip Lung, Philip Shorvon. Virtual Touch Quantification Elastography for Non-invasive Assessment of Liver Disease and Its Complications. What the Clinical Needs to Know..//Frontline Gastroenterology,2017;8(1): 37-44. https://dx.doi.org/10.1136%2Fflgastro-2016-100729
  12. Postnova NA, Borsukov AV, Morozova TG et al. Compression liver elastography: a technique, peculiarities of obtaining elastograms, analysis of errors and artifacts. Radiology-practice. 2(50). Pp. 45–54.
  13. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography// J. Hepatol. - 2008. - V. 48. - P. 835-847. https://doi.org/10.1016/j.jhep.2008.02.008
  14. EASL-ALEH Clinical Practice Guidelines: Noninvasive tests for evaluation of liver disease severity and prognosis // Journal of Hepatology. 2015. - Vol. 63. - P. 237-264. https://doi.org/10.1016/j.jhep.2015.04.006

Full text is published :
Vinnitskaya E. V., Keiyan V. A., Sandler Yu.G., Khaimenova T. Yu., Polukhina A. V. ESTIMATION OF EFFICIENCY OF TRANSIT FIBROELASTROMETRY IN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH OBESITY. Experimental and Clinical Gastroenterology Journal. 2018;152(04):09-17
Read & Download full text

1. State geriatric center (Netanya, Israel)
2. Republican scientific and practical center of children’s surgery (Minsk, Belarus)

Abstract:Objective: to determine the possibility of screening for gastroesophageal reflux disease (GERD) by size and shape of the stomach gas bubble on the direct X-ray of the chest and abdomen. Methods and results. One hundred seventy-five radiographs of patients of different ages were analyzed by the random sampling method. The shape of the stomach gas bubble (SGB) was determined and its width and height were measured. Results. SGB was detected in all pediatric patients. It was absent in 18% of adults (16-64 years) and in 25% of the patients aged 65 years and older. In majority of patients fundus had a shape of a dome with the level of liquid content. In 6% of patients the SBG was deformed with an angular protrusion in the shape of the «bird beak» pointing in the direction of the spine. The more advanced was the age of a patient the more increase in volume of SBG we observed in the sagittal plane. In the direct projection, age had no significant influence on the average size of the SGB (except without SGB). There was a significant increase in the width of GBS in older children (7-15 years) compared to children aged 1-6 years. In adults, there was a tendency to have smaller width and height of SBG (P> 0.1). In elderly, we found a significant decrease in these parameters. Discussion. The size of the dome of SGB, which is a «trap» for the air, depends on the stability of its walls. In GERD the intraperitoneal portion of the lower esophageal sphincter is weakened and is opened either temporarily under the pressure, or permanently. In such cases, the dome is deformed with the formation of a corner protrusions, and reduced in size. Conclussion. The absence of GBS, or the decrease of its size, or the angular protrusion of its inner wall on the x-ray suggest the possibility of GERD. Further research is needed to determine the normal width and height of GBS.

• References total 16 ⇓ :: .
  1. Pounderoux P, Ergun G.A, Lin S, et al. Esophageal bolus transit imaged by ultrafast computerized tomography. Gastroenterology. 1996 May;110(5):1422-8.
  2. Holloway R.H, Hongo M, Berger K, Mc Callum R.W. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985 Oct;89(4):779-84.
  3. Scheffer R.C, Akkermans L.M, Bais J.E, et al. Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil. 2002 Dec;14(6):647-55.
  4. Enzmann D.R, Harell G.S, Zboralske F.F. Upper esophageal responses to intraluminal distention in man. Gastroenterology. 1977 Jun;72(6):1292-8.
  5. Bredenoord A.J, Weusten BLAM, Sufrim D, et al. Aerophagia? Gastric? And supragastric belching: a study using intraluminal electrical impedance monitoring. Gut. 2004 Nov;53(11):1561-5.
  6. Bredenoord A.J, Weusten BLAM, Timmer R, et al. Relationships between air swallowing, intragastric air, belching and gastro-oesophageal teflux. Neurogastroenterol Motil. 2005 Jun;17(3):341-7.
  7. Watanabe T, Urita Y, Maeda T, et al. Changes in a gastric air bubble linked to gastroesophageal reflux symptoms. J Breath Res. 2008 Sep;2(3):037024. doi: 10.1088/1752-7155/2/3/037024. Epub 2008 Sep 8.
  8. Watanabe T, Urita Y, Maeda T, et al. Form of gastric air bubble is associated with gastroesophageal reflux symptoms. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1566-70.
  9. Levin M. D., Khomich V. M., Nalibotskiy B. V. O vozmozhnosti rentgendiagnostiki ostrogo appenditsita u detey. Klin Khirurgiya. 1989, no.6, pp.38–40. (In Russ.)
  10. Levin M. D. Rentgenologicheskaya diagnostika ostroy kishechnoy neprokhodimosti u detey. Zdravookhraneniye Belorussii. – 1987, no.12, pp.11–15. (In Russ.)
  11. Isolauri J., Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Med. 1995. - № 27. -P. 67-70.
  12. Karamanolis G.,Kotsalidis G., Triantafyllou K., et al. Yield of Combined Impedance-pH Monitoring for Refractory Reflux Symptoms in Clinical PracticeNeurogastroenterol Motil. 2011. - Vol.17, № 2. - P. 158-163.
  13. Shaker R, Dodds W.J, Kahrilas P.J, et al. Relationship of intraluminal pH and pressure within the lower esophageal sphincter. Am J Gastroenterol. 1991 Jul;86(7):812-6.
  14. Ackermann C., Rothenbhler J.M., Martinoli S., Muller C. Esophagealmanometry prior to and following anti-reflux surgery. Schweiz. Med. Wochenschr.1991; 121 (21): 797-800.
  15. Peng L, Patel A, Kushnir V, Gyawali C.P. Assessment of Upper Esophageal Sphincter Function onHigh-resolution Manometry: Identification of Predictors of Globus Symptoms. J Clin Gastroenterol. 2014 Jan 31. [Epub ahead of print].
  16. Vegesna A.K, Sloan J.A, Singh B, et al. Characterization of the distal esophagus high-pressure zone with manometry, ultrasound and micro-computed tomography. Neurogastroenterol Motil. 2013 Jan;25(1):53-60.e6. doi: 10.1111/nmo.12010. Epub 2012 Sep 24.

Full text is published :
Levin M. D., Jin I. G. SCREENING OF GASTROESOPHAGEAL REFLUX DISEASE BASED ON THE SIZE OF THE GASTRIC GAS BUBBLE. Experimental and Clinical Gastroenterology Journal. 2018;152(04):23-29
Read & Download full text

1. FSBEI HPE rnsmu. N. And. Pirogov (Moscow, Russian Federation)
2. City Clinical Hospital № 17 (Moscow, Russian Federation)
3. ”K+31” Clinic (Moscow, Russian Federation)
4. City Clinical Hospital № 31 (Moscow, Russian Federation)
5. Lomonosov Moscow State (Moscow, Russian Federation)

Keywords:anastomotic ulcers, small bowel bleeding, small bowel resection, enteroscopy

Abstract:Objectives: to evaluate the etiology of anastomotic ulcers (AU), being the sources of small bowel bleeding, using clinical, instrumental features and results of treatment. Materials and methods: From 14.02.2007 to 30.10.2017 from 213 patients, having applied to our hospital with suspected small bowel bleeding, AU were revealed in 8 (3,7%) pts (m-7, f-1, mean age 38,0±14,4 years, range 19-59). There were 7 (87,5%) pts. with obscure overt and 1 (12,5%) with obscure occult bleeding. Diagnostic procedures included videocapsule endoscopy (VCE) and balloon-assisted enteroscopy (BAE) in all of pts. VCE was performed in 6 (75,0%) pts, followed by BAE, which was ineffective in 2 cases. BAE was performed in all 8 pts: it was effective in 6 cases, including 2 pts without previous VCE. Results: Anastomotic ulcers were initially revealed, using VCE, in all cases, then - confirmed using BAE (4) and surgery (2); using only BAE - in 2 pts. Initial conservative treatment, recommended to 6 (75,0%) pts, was effective in 1 case; in other 5 cases surgery was performed because of persisted anemia and rebleeding episodes. Surgery at once was performed in 2 (25,0%) pts. After surgery and histology in 7 pts we revealed ulcers at the anastomotic area in 4 (57,1%) pts, in the middle of long blind loops area in 3 (42,9%) pts. Signs of ischemia and Crohn’s disease were not revealed. Suture material was detected in ulcer bases in 2 (28,6%) pts. All patients have been free of relapse (1-7 years). Conclusions: Using VCE and BAE gave the opportunity to reveal the source of bleeding in pts with AU, suffering for a long time. Having analysed surgery and histology results in 7 pts, we can suppose, that long blind loops, as well as suture material can lead to anastomotic ulceration in patients after SB resection. Further accumulation of clinical material is needed for complete analysis of etiology of AU.

• References total 13 ⇓ :: .
  1. Bhargava S.A. et al. Gastrointestinal bleeding due to delayed perianastomotic ulcers in children. Am J Gastroenterol 1995; 90:807-809.
  2. Charbit-Henrion F. et al. Anastomotic ulcerations after intestinal resection in infancy. Gastroenterology. 2014; 59 (4): 531-536.
  3. Chari S.T. et al. Ileocolonic Anastomotic Ulcers: A case series and review of the literature. The American Journal of gastroenterology. 2000. Vol.95 (5): 1239-1243.
  4. Fisher L.R., Krinsky L. Anderson M. A. et al. The role of endoscopy in the management of obscure GI bleeding. Gastrointestinal Endoscopy. 2010; 72 (3): 471-479.
  5. Goldszmidt D, Duche M, Gauthier F. Small intestine ulcers 12 years after ileosigmoid anastomosis for neonatal necrotizing enterocolitis. Arch Pediatr. 1994; 1:1011-1013.
  6. Gomez E., Valls F. et al. Postoperative small bowel and colonic anastomotic bleeding. Therapeutic management and complications. Cirugia Espanola. 2014; 92 (7): 463-467.
  7. Gurudu R., Bruining D., Acosta R. et al. The role of endoscopy in the management of suspected small-bowel bleeding. ASGE Guideline. Gastrointestinal Endoscopy. 2016: 1-10.
  8. Hamilton A.H et al. Severe anemia and ileocolic anastomotic ulceration. Arch Dis Child. 1992; 67:1385-1386.
  9. Paterson C.A. et al. Late anastomotic ulceration after ileocolic resection in childhood. Can J Surg. 1993; 36: 162-164.
  10. Pennazio M., Eisen G., Goldfarb N. ICCE Consensus for Obscure Gastrointestinal Bleeding. Endoscopy. 2005; 37 (10): 1046-1050.
  11. Sonheimer J.M et al. Anastomotic ulceration: a late complication of ileocolonic anastomosis. L Pediatr. 1995; 127:225-230.
  12. Weinstock L. B. Endoscopic abnormalities of the anastomosis following resection of colonic neoplasm. Gastrointestinal Endoscopy. 1994; 40: 558-561.
  13. Ivanova E. V. Sovremennyye metody enteroskopii v diagnostike i lechenii zabolevaniy toshchey i podvzdoshnoy kishki. Doct. Diss. [Modern methods of enteroscopy in the diagnosis and treatment of diseases of the jejunum and ileum. Dr. med sci. diss.] Moscow, 2013. 269 p

Full text is published :
Ivanova E.V., Tikhomirova E.V., Larichev S.E., Yudin O.I. et al. ULCERS THIN-INTESTINAL ANASTOMOSIS AS THE SOURCE OF BLEEDING IN PATIENTS WITH RESECTION OF THE SMALL INTESTINE IN HISTORY. Experimental and Clinical Gastroenterology Journal. 2018;152(04):30-36
Read & Download full text

1. Eramishantsev Clinical Hospital (Moscow, Russian Federation)
2. State Research and Clinical Center for Laser Medicine (Moscow, Russian Federation)
3. Peoples’ Friendship University of Russia (Moscow, Russian Federation)

Keywords:malignant colon obstruction, colorectal stenting

Abstract:The aim of the study was to analyze the results of inpatient treatment of patients with malignant colonic obstruction with the use of colorectal stents, and identify the factors associated the unfavorable result of treatment. Materials and methods. The study included 102 patients who, from December 2012 to August 2017, made an urgent attempt to stenting. Stenting was performed under combined (X-ray and endoscopic) control. Double coated and uncovered stents were used. Results. The clinical and technical success rate were 97.0 and 94.1%, respectively. The incidence of complications in the immediate postoperative period was 3.1%. Inpatient mortality rate was 6.1%. The duration of symptoms of colon obstruction is associated with the outcome of an unfavorable outcome. Conclusion. Colorectal stenting is an effective and relatively safe method of relieve of obstructive colonic obstruction of tumor origin. It is necessary to continue the study to assess the long-term outcome of treatment.

• References total 15 ⇓ :: .
  1. WHO Cancer country profile 2014 http://www.who.int/cancer/country-profiles/rus_ru.pdf?ua=1
  2. Sousa M., Pinho R., Proeсna L., Silva J. Predictors of Complications and Mortality in Patients with Self-Expanding Metallic Stents for the Palliation of Malignant Colonic Obstruction. Port J Gastroenterol, 2017, Vol. 24, pp.122-128.
  3. Vodoleev A. S., Duvanskiy V. A. Colorectal stenting for the treatment of malignant colonic obstruction. Experimental and Clinical Gastroenterology Journal. 2017;139(3):60–66.
  4. Kobborg M., Broholm M., Frostberg E., Jeppesen M., Gögenür I. Short-term results of self-expanding metal stents for acute malignant large bowel obstruction. Colorectal Diseases, 2017, Vol. 19, O365-O371
  5. Meisner S., González-Huix F., Vandervoort J. G., et al. Self-expandable metal stents for relieving malignant colorectal obstruction: short term safety and efficacy within 30 days of stent procedure in 447 patients. Gastrointestinal Endoscopy, 2011, Vol.74, pp. 876-884.
  6. Mitra V., Hu M., Majumdar D., Krishnan V. Safety and efficacy of self-expandable metal stents for obstructive proximal and distal large bowel cancer. J R Coll Physicians Edinb, 2017, Vol. 47, pp. 30-34.
  7. Sharma S. K., Milsom J. W. The evolution of surgery for the treatment of malignant large bowel obstruction Techniques in Gastrointestinal Endoscopy, Vol. 16, Issue 3, pp. 112-118.
  8. van Hooft J. E., Bemelman W. A., Oldenburg B., Marinelli A. W. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol, 2011, Vol.12, pp. 344-352.
  9. Han S.H., Lee J. H. Colonic stent-related complications and their management. Clinical Endoscopy,2014, Vol. 47, pp. 415-419.
  10. Matsuzawa T., Ishida H., Yoshida S., Isayama H. A Japanese prospective multicenter study of self-expandable metal stent placement for malignant colorectal obstruction: short-term safety and efficacy within 7 days of stent procedure in 513 cases. Gastrointestinal Endoscopy, 2015, Vol. 82, pp. 697-707.
  11. van Halsema E. E., van Hooft J. E. Outcome and complications of stenting for malignant obstruction. Techniques in Gastrointestinal Endoscopy, 2014, Vol.16, pp.129-134.
  12. Nagula S., Ishill N., Nash C., Markowitz A. J. Quality of Life and Symptom Control after Stent Placement or Surgical Palliation of Malignant Colorectal Obstruction. American College of Surgeons.2010, Vol. 210, No. 1, January, pp. 45-53.
  13. Baron T.H., Wong Kee Song L. M., Repici A. Role of self-expandable stents for patients with colon cancer. Gastrointestinal Endoscopy, 2012, Vol.75, pp. 653-62.
  14. Reeders J.W., Rosenbusch G., Tytgat G. N. Ischaemic colitis associated with carcinoma of the colon. Eur J Radiol, 1982, Vol.2, pp. 41-47.
  15. Sasaki K., Kazama S., Sunami E., et al. One-stage segmental colectomy and primary anastomosis after intraoperative colonic irrigation and total colonoscopy for patients with obstruction due to left-sided colorectal cancer. Dis Colon Rectum, 2012, Vol. 55, pp. 72-78.

Full text is published :
Vodoleev A.S., Duvanskiy V.A., Malyuga V.Yu., Kryazhev D.L. SHORT-TERM RESULTS OF COLORECTAL STENTING IN PATIENTS WITH MALIGNANT LARGE BOWEL OBSTRUCTION. Experimental and Clinical Gastroenterology Journal. 2018;152(04):37-41
Read & Download full text

1. Interregional Clinical-Diagnostic Center
2. Kazan State Medical Academy — Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (Kazan, Russian Federation)
3. Kazan (Volga region) Federal University (Kazan, Russian Federation)
4. Kazan State Medical University (Kazan, Russian Federation)

Keywords: endopapillary interventions, early postmanipulation complications, treatment of choledocholithiasis, sphincter of Oddi insufficiency

Abstract:Aim: Modern technologies involve the use of minimally invasive interventions in the treatment of choledocholithiasis, however, despite the improvements in endoscopic techniques, the total number of early complications is still at a consistently high level and is 0.8-20%, with mortality rates of 1.5-2%. Sphincter of Oddi insufficiency, stenosis of major duodenal papilla, the recurrence of choledocholithiasis are most common complications at late stages after the endoscopic papillosphincterotomy. Еndopapillary interventions are the “gold” standard of choledocholithiasis treatment and increasing their safety requires further study and development. Result: A “Method of endoscopic treatment of choledocholithiasis and prevention of postmanipulation complications” (Patent of Russian Federation for invention № 2644307 dated by 08.02.2018) was devepoled. Thirty seven patients with choledocholithiasis were treated according to the proposed method during the period of 2016-2017. Early postoperative complications were not observed. Transient amylasemia was revealed in 12 patients (32%). Signs of sphincter of Oddi insufficiency were found in 1 of 7 patients (14.3%) who underwent hepatobiliscintigraphy. Conclusion: The developed method of endoscopic treatment of choledocholithiasis allows to prevent the development of early and late postmanipulation complications.

• References total 21 ⇓ :: .
  1. Aliev Iu. G. Miniinvasive surgery for the treatment of the complicated cholelithiasis. Khirurgiya. Zhurnal imeni N. I. Pirogova. 2013;(5):73–75.
  2. Gal’perin E.I., Vetshev P. S. Mannual of bile duct surgery. Moscow: Vidar-M; 2006. 362 p. Russian
  3. Akhaladze G. G. Choledocholithiasis. Cholangitis and Biliary Sepsis: in What Lies the Difference? Annaly khirurgicheskoy gepatologii. 2013;18(1):54–58.
  4. Shapovalyants S. G., Ardasenov T. B., Pankov A. G., Budzinsky S. A., Veselova V. S. Difficult choledocholithiasis – result of overdue surgical treatment of gallstone disease. RJGHC. 2013. Vol.23: no.4, pp.15–21.
  5. Colton J.B, Curran C.C. Quality indicators, including complications, of ERCP in a community setting: a prospective study. Gastrointest. Endosc. 2009; 70 (3): 457-467.
  6. Kapral C, Duller C, Wewalka F, Kerstan E, Vogel W, Schreiber F. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy. 2008; 40 (8): 625-630.
  7. Gomutbutra T. Risk factors and techniques affecting surgical outcome of therapeutic endoscopic retrograde cholangiopancreatography difficulties. J Med Assoc Thai. 2005; 88 (8): 1103-9.
  8. Bystrovskaia E. V., Orlova Iu. N. Choledocholithiasis occurrence in postcholecystectomic syndrome. Eksp Klin Gastroenterol. 2008;(3):33–6
  9. Sayfutdinov I. M., Slavin L. E., Muraviyov V. Yu., Ivanov A. I. Endosonography as a method of prevention compications retrograte transpapillary interventions. Oncology bulletin of the Volga region. 2016;24(2):59–65.
  10. Nechitailo M. Ye., Ogorodnik P. V., Belyaev V. V. et al. Complications of endoscopic transpapillary interventions. Clinical surgery. 2006; no.8, pp. 19–21. (In Russ.)
  11. Bagnenko S. F., Каbаnоv М. U., Iakovleva D. М., Degtyarev D. B., Pirlekov D. R., Кrаdenov А. V., Bunin V. А. Optimizing of treatment strategy of patients with cholelithiasis complicated by choledocholithiasis. vestnik-rossijskoi-voenno-meditsinskoi-akademii 2011,35(3):35–42.
  12. Mandryka Y, Klimczak J, Duszewski M, Kondras M, Modzelewski B. Bile duct infections as a late complication after endoscopic sphincterotomy. Pol Merkur Lekarski. 2006; 21 (126): 525-7.
  13. Chan H.H, Lai K.H, Lin C.K, Tsai W.L, Peng N.J, Hsu P.I, Lo G.H, Wei M.C, Wang E.M, Chang H.W. Impact of food on hepatic clearance of patients after endoscopic sphincterotomy. J Chin Med Assoc. 2009; 72 (1): 10-4.
  14. Yurchenko V. V. Some aspects of endoscopic sphincterotomy and corresponding control. Siberian Medical Journal (Irkutsk). 2005;58(8):19–21.
  15. Shapoval’yanets SG, Fedorov ED, Orlov S. Yu., Galkova Z. V. Endoscopic balloon dilatation of the sphincter of Oddi is a modern alternative to papillosphincterotomy in the treatment of choledocholithiasis. Endoskopicheskaya khirurgiya 2001, no.4, pp:48–56.
  16. Kondo S, Yamamoto N, Nakai Y, Sasahira N, Hirano K, Tsujino T, Isayama H, Toda N, Komatsu Y, Tada M, Yoshida H, Kawabe T, Otomo K, Omata M. Preservation of papillary relaxation after endoscopic papillary balloon dilation. Hepatogastroenterology. 2008; 55 (84): 855-858.
  17. Weinberg B.M, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006; 4: CD004890.
  18. Kochhar R, Dutta U, Shukla R, Nagi B, Singh K, Wig J.D. Sequential endoscopic papillary balloon dilatation following limited sphincterotomy for common bile duct stones. Dig. Dis. Sci. 2009; 54 (7): 1578-1581.
  19. Li N.P, Liu J.Q, Zhou Z.Q, Ji T.Y, Cai X.Y, Zhu Q.Y. Ampulla dilation with different sized balloon store move common bile duct stones. World J Gastroenterol. 2013; 19 (6): 903-908.
  20. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointestinal Endoscopy. 2001; 54 (2): 209-13.
  21. Espinel J, Pinedo E. Large balloon dilation for removal of bile duct stones. Rev. Esp. Enferm. Dig. 2008; 100 (10): 632-636.

Full text is published :
Sayfutdinov I.M.1, Slavin L.E., Khayrullin R.N.1, Abdulkhakov S.R. et al. A NEW METHOD OF ENDOSCOPIC TREATMENT OF CHOLEDOCHOLITHIASIS AND PREVENTION OF POSTMANIPULATION COMPLICATIONS. Experimental and Clinical Gastroenterology Journal. 2018;152(04):42-47
Read & Download full text

1. Sechenov University (Moscow, Russian Federation)
2. Moscow City Clinical Hospital № 15 named after O. M. Filatov (Moscow, Russian Federation)

Keywords: acute biliary pancreatitis, incarcerated calculus, major duodenal papilla, endoscopic decompression of bile ducts

Abstract:Aim: To evaluate the factors affecting the development of acute biliary pancreatitis by incarcerated calculus of the terminal portion of the common bile duct. Materials and methods: The results of treating 60 patients with incarcerated calculus of the terminal portion of the common bile duct after endoscopic intervention on the major duodenal papilla were analyzed. Results: Patients were divided into two groups: with acute pancreatitis (group 1, n = 34) and with no changes in the pancreas (group 2, n = 26). To compare the groups, laboratory, and endoscopic results were analyzed. According to case history, 26 patients (76%) from group 1 and 2 patients (8%) from group 2 had chronic pancreatitis. There was also a decrease in the development of acute pancreatitis to 11.8% of cases in patients who had undergone early (less than 6 hours) endoscopic papillotomy and lithotomy. Conclusion: It is established that the presence in the history of chronic pancreatitis, cholelithiasis, and concomitant purulent cholangitis is a prognostic criterion for the development of acute biliary pancreatitis. It is established that acute biliary pancreatitis may develop due to chronic pancreatitis, cholelithiasis, and concomitant purulent cholangitis in history as well as due to late (more than 6 hours) decompression and sanation of bile ducts.

• References total 16 ⇓ :: .
  1. Andryushchenko V. P., Lysyuk Yu. S. Kholedokholitiaz i ostryy biliarnyy pankreatit: lechebno-takticheskiye aspekty [Choledocholithiasis and acute biliary pancreatitis: therapeutic and tactical aspects]. Annaly khirurgicheskoy gepatologii – Annals of surgical hepatology. 1998;3(3), pp.31–32.
  2. Voskresenskiy O. V., Timoshin A. D., A. A. Movchun A. A., Skripenko O. G. Biliary complications of chronic pancreatitis: diagnosis, surgical tactics. Rus J Gastroenterol Hepatol Coloproctol 1994; 4(3):26–31
  3. Gal’perin E.I., Dyuzheva T. G., Akhaladze G. G. «Reshennyye» i «nereshennyye» voprosy lecheniya tyazhelogo ostrogo pankreatita [“Solved” and “unresolved” issues of the treatment of severe acute pancreatitis]. Annaly khirurgicheskoy gepatologii – Annals of surgical hepatology. 2007, no.3, pp.173–182.
  4. Kondratenko P. G., Stukalo A. A. Minimally invasive technologies in patients with acute obstruction of terminal common bile duct. Ukrainian journal of surgery. 2013;22(3), pp.80–83.
  5. Kotovskiy A. Ye; Dyuzheva T. G.; Glebov K.G; Shefer A. V., Dzhus Ye. V. Endoskopicheskoye drenirovaniye glavnogo pankreaticheskogo protoka pri ostrom pankreatite [Endoscopic drainage of the main pancreatic duct in acute pancreatitis.]. IV Belomorskiy kongress. Vserossiyskaya konferentsiya s mezhdunarodnym uchastiyem [IV The White Sea Congress. All-Russian conference with international participation] Arkhangelsk, 2011, pp. 18
  6. Maystrenko N. A., Stukalov V. V. Kholedokholitiaz [Choledocholithiasiss]. SPb, ELBI-SPb Publ., 2000. 288 p.
  7. Mamedov S. H., Klimov A. E., Nazarov D. T., Sadovnikova Е. Yu. Diagnostic markers of acute cholangitis in biliary pancreatitis in patients with impacted stones of the major duodenal papilla. Medical Herald of the South of Russia. 2017: 8 (3); 64–70
  8. Nichitaylo M. Ye., Ogorodnik P. V., Deynichenko A. G., Kolomiytsev V.I, Khrystyuk D. I. Minimal’no invazivnaya patologiya oslozhnennykh form kholedokholitiaza [Minimal invasive pathology of complicated forms of choledocholithiasis] Khar’kivska khirurgichna shkola – Kharkiv school of science 2013: 59 (2); 12–17
  9. Tolstoi A. D., Bagnenko S. F., Krasnogorov V. B. et al. Acute pancreatitis: diagnostic and treatment protocols. Pirogov Russian Journal of Surgery. 2005, no.7, pp.19–23.
  10. Savel’yev V. S. Pankreonekroz. Sostoyaniye i perspektiva [Pancreatic necrosis. Condition and perspective]. Moscow, Meditsina Publ., 1983, 240 p.
  11. Filimonov M. I., Burnevich S. Z. Khirurgiya pankreonekroza. 50 lektsiy po khirurgii. Pod redaktsiyey V. S. Savel’yeva [Surgery of pancreatic necrosis. 50 lectures on surgery. Edited by V. S. Savel’eva]. Moscow, 2003, 243–250 p.
  12. Yarosh A. L. Diagnostika, prognozirovaniye iskhodov i lecheniye kholedokholitiaza i yego oslozhneniy. Diss. dokt. med. Nauk [Diagnosis, prognosis of outcomes and treatment of choledocholithiasis and its complications. Doct. Diss.]. Belgorod, 2013. 293 p.
  13. Fan S.T., Lai E. C.S., Mok F. et al. Early treatment of acute biliary pancreatitisby endoscopic papillotomy. N. Engl. J. Med. 1993., Т. 328., P. 228-232
  14. Folsch U. R., Nitsche R., Ludtke R. Early ERCP and papillotomy compared withconservative treatment for acute biliary pancreatitis, The German Study Group onAcute Biliary Pancreatitis, N. Engl. J. Med.,1997, Vol. 336. P. 237-242
  15. Lerch M., Aghdassi Ali. Gallstone-related pathogenesis of acute pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base[Internet]. 2016. Available from:: http:// dx.doi.org/10.3998/panc.2016.24. doi: 10.3998/panc.2016.2
  16. Takano Y., Nagahama M., Maruoka N., Yamamura E. Clinical features of gallstone impaction at the ampulla of Vater and the e ectiveness of endoscopic biliary drainage without pa- pillotomy. Endosc Int Open. - 2016., V.04(07), P. 806-811

Full text is published :
Zvereva A.A., Kotovsky A.E., Glebov K.G., Dyuzheva T.G.PREDICTORS, THAT INFLUENCE THE DEVELOPMENT OF ACUTE PANCREATITIS WITH AN INCARCERATED CALCULUS OF THE SPHINCTER OF ODDI. Experimental and Clinical Gastroenterology Journal. 2018;152(04):48-52
Read & Download full text

1. Novokuznetsk State Institute for Further Training of Physicians — Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation (Novokuznetsk, Russian Federation)
2. Municipal Hospital Nr.29 (Novokuznetsk, Russian Federation)

Keywords: chronic gastritis, endoscopic diagnosis, microscopic diagnosis

Abstract:Article is devoted to the analysis of compliance of endoscopic and histological studies of different forms of chronic gastritis. Results of inspection of 3593 pa-tients with chronic gastritis are studied in long dynamic observation. The analysis of endoscopic signs in a descriptive picture of chronic gastritis irrespective of prescription of a disease has revealed three main general signs: diversity, unevenness, foci of atrophy of gastric mucosa. Analysis of the microscopic picture showed the same atrophic-hyperplastic processes of varying degrees of severity in different forms of chronic gastritis (hypertrophic - nodular, verrucous, polypoid, small and large focal atrophic gastritis). There is high degree of correlation between the endoscopic and microscopic features. The scheme of development and interpretation of chronic gastritis is offered. Use in practice of the endoscopist the conclusion “chronic subatrophic gastritis” to a stage “chronic atrophic gastritis” is proved.

• References total 25 ⇓ :: .
  1. Kononov A. V., Mozgovoi S. I., Shimanskaya A. G. et al. Immunohistochemical detection of biomolecular markers for metaplastic mucosal atrophy in gastric biopsy specimens. Archive of pathology. 2014;76(6):44–50
  2. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994/ Dixon MF, Genta RM, Yardley JH, Correa P. // Am J Surg Pathol 1996; 20: 1161–81.
  3. Gastritis staging in clinical practice: the OLGA staging system/ Rugge M, Meggio A, Pennelli G, et al. // Gut 2007; 56: 631–636.
  4. Mozgovoy S. I., Shimanskaya A. G., Osintseva I. L. et al. Russian revision of the international classification of chronic gastritis: evaluation of a new diagnostic approach using kappa statistics./ Omsk Scientific Bulletin, 2010;1(94):84–88
  5. McMahon RFT. Reporting gastritis – relevant and irrelevant information // BDIAP Meeting Ainley Top May 2010
  6. Shimanskaya A. G. Morphological methods and expert approach in verifying the atrophy of the gastric mucosa in the biopsy diagnosis of atrophic gastritis. Young Scientist. April, 2012;4(39):496–504
  7. Kayaçetin S., Güreşçi S. What is gastritis? What is gastropathy? How is it classified?// Turk J Gastroenterol 2014; 25: 233–247
  8. In vivo histopathology using endocytoscopy for non-neoplastic changes in the gastric mucosa: a prospective pilot study (with video)/ Sato H., Inoue H., Hayee B. H. et al.// Gastrointest Endosc 2015; 81: 875–881
  9. Genta R M, Rugge M. Gastric precancerous lesions: heading for an international consensus// Gut 1999; 45 (Suppl I): I5–I8
  10. Block B., Schachschal G., Schmidt H. Endoscopy of the Upper GI Tract: – Georg Thieme Verlag, 2004
  11. Saveliev V. S., Buyanov V. M. Guide to clinical endoscopy. Moscow; 1985
  12. Endoscopy of the gastrointestinal tract / Ed. prof. S. A. Blashentseva. Moscow: GEOTAR-Media Publ., 2009. pp. 520: ill. (Library of the specialist doctor).
  13. Rapoport S. I. Gastrites (Manual for doctors). Moscow, "Medpraktika-M" Publ., 2010. pp. 20
  14. Desai H. G. Investigations Proposed to Accurately Classify Chronic Gastritis// JAPI April 2007; Vol. 55: 293–296
  15. Volova A. V. Complex endoscopic examination in the diagnosis of chronic gastritis: author's abstract. diss. Ph.D., Moscow, 2006
  16. Conventional videoendoscopy can identify Helicobacter pylori gastritis?/ Gomes A., Skare T. L., Prestes M. A. et al. // ABCD Arq Bras Cir Dig 2016; 29 (2): 73–76
  17. Atlas of Gastrointestinal Endoscopy@Endoscopic Biopsis/Emory T.S., Carpenter H. A., Gostout C. J., Sobin L. H.: Armed Forces Institute of Pathology, American Registry of Pathology, Washington, 2000
  18. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication/ Shichijo S., Hirata Y., Niikura R.et al.// Gastrointest Endosc 2016;84: 618–624
  19. Aruin L. I., Grigoriev P. Ya., Isakov V. A., Yakovenko E. P. Chronic gastritis: Amsterdam; 1993: pp. 308
  20. Shestakov A. G. Morphological characteristics and morphogenesis of chronic gastritis stump of the stomach: author's abstract. diss. Ph.D., Chelyabinsk, 2004
  21. Marzhatka Z. – Endoscopy of the digestive tract: Nomenclature OMED – M .: Olympus, 1996. – 136 p.
  22. Atlas of GE and Related Pathology/ K.F.R. Schiller, R. Cockel, R. H. Hunt, B. F. Warren. – Blackwell Science, 2004
  23. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its signifiance in chronic gastritis// Endoscopy 1969;3:87–97.
  24. Autoimmune Gastritis. A Clinicopathologic Study of 25 Cases/ Chlumská A., Boudová L., Beneš Z., Zámečník M.// Čes.-slov. Patol., 41, 2005, No. 4, p. 137–142
  25. Kononov A. V., Mozgovoi S. I., Markelova M. V., Shimanskaya A. G. Biomarker principle of atrophy detection of gastric mucosa in chronic gastritis. Prospects of Science. 2013;10(49):58–61

Full text is published :
Korotkevich A.G., Aksenov P.V. TO ENDOSCOPIC CLASSIFICATION OF CHRONIC GASTRITISES. Experimental and Clinical Gastroenterology Journal. 2018;152(04):53-59
Read & Download full text

1. Ryazan State Medical University (Ryazan, Russian Federation)

Keywords:Laparoscopic choledocholithotomy, choledocholithiasis, video-endoscopic techniques

Abstract:Purpose: Improve treatment outcomes in patients with cholelithiasis complicated by choledochal-tiasa, through the introduction and improvement of the videoendoscopic technology. Materials and methods: 97 patients with cholelithiasis complicated by choledocholithiasis and/or stenosing duodenal papillitis is divided into two homogeneous groups. In the main group (n=47) of the patients operated using laparoscopy, in control (n=50) - laparotomy. Results: the Average duration of surgery in both groups were not significantly different. The level of postoperative pain in patients of the main group was significantly lower than the comparison group. Light postoperative complications observed were given in 17 cases of the main group (36.2%) and in 24 patients in the control group (48.0 per cent). In 1 patient of the main group diagnosed subhepatic abscess, developed shenny by drainage under ULTRASOUND control. 3 patients of the control group, postoperative wound suppuration. In each of the groups, there was 1 case of insolvency of choledochojejunoanastomosis. Conclusions: Laparoscopic access has no effect on the duration of operation of the radio and can significantly reduce the intensity of postoperative pain. Often, the early postoperative complications after laparoscopic choledocholithotomy-MII does not exceed the frequency of complications after choledocholithotomy performed laparoscopy-volume access.

• References total 7 ⇓ :: .
  1. Kuznetsov Yu. N. Endosurgical technologies in the treatment of acute cholecystopancreatitis. I. P. Pavlov Russian Medical Biological Herald. 2004; no. 1–2: pp.125–130. (In Russ)
  2. Natalskiy A. A., Tarasenko S. V., Peskov O. D. The problem of liver failure in surgery. Eruditio Juvenium. 2013; no.1, pp. 61–73.
  3. DuCoin C., Moon R., Teixeira A. Laparoscopic choledochoduodenostomy as an alternate treatment for common bile duct stones after Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2014, vol. 10, no.4, pp. 647-652.
  4. Hawker G. et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale. Arthritis Care & Research, 2011, vol. 63, no.11, pp. 240-252.
  5. Dindo D., Demartines N., Clavien P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004 vol. 240, no.2, pp. 205-213.
  6. El Nakeeb A., Askr W., El Hanafy E. Long term outcomes of choledochoduodenostomy for common bile duct stones in the era of laparoscopy and endoscopy. Hepatogastroenterology, 2015, vol. 62, no.137, pp 6-10.
  7. Yi, H., Hong G., Min S. Long-term outcome of primary closure after laparoscopic common bile duct exploration combined with choledochoscopy. Surg Laparosc Endosc Percutan Tech, 2015, vol. 25, no. 3, pp 250-253.

Full text is published :
Tarasenko S. V., Zaitsev O. V., Tyulenev D. O., Kopejkin A. A., Rakhmaev T. S., Bogomolov A. Yu. COMPARATIVE ANALYSIS OF IMMEDIATE RESULTS OF LAPAROSCOPIC AND LAPAROTOMIC OF CHOLEDOCHOLITHOTOMY. Experimental and Clinical Gastroenterology Journal. 2018;152(04):60-65
Read & Download full text

1. North-Western state medical University named after I. I. Mechnikov (St. Petersburg, Russian Federation)
2. Saint-Petersburg I. I. Dzhanelidze research institute of emergency medicine (St. Petersburg, Russian Federation)

Abstract:The article describes the range of possibilities of endobiliary interventions in the treatment of obstructive jaundice and main conditions for the successful operation on the large duodenal papilla with paraphateral diverticula. Key words: large duodenal papilla, paraphateral diverticulum, obstructive jaundice, endoscopic interventions.

• References total 15 ⇓ :: .
  1. Bykov M. I., Porkhanov V. A. Endoscopic transpapillary lithoextraction in case of parapapillary diverticulum. Khirurgiya, 2015. – № 10. – С. 78–81
  2. Andriulli A., Loperfido S., Napolitano G., Niro G., Valvano M. R., Spirito F., Pilotto A., Forlano R. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. American Journal of gastroenterology, 2007; 102(8): 1781-1788 DOI:10.1111/j.1572-0241.2007.01279.x
  3. Naoto Egawa, Hajime Anjiki, Kensuke Takuma, Terumi Kamisawa. Juxtapapillary duodenal diverticula and pancreatobiliary disease. Digestive surgery, 2010; 27:105-109. DOI: 10.1159/000286520
  4. Tyagi P., Sharma P., Sharma B.C., Puri A.S. Periampullary diverticula and technical success of endoscopic retrograde cholangiopancreatography. Surg Endosc. 2009 Jun; 23(6): 1342-5. DOI: 10.1007/s00464-008-0167-7
  5. Chiang T.H, Lee Y.C, Chiu H.M, Huang S.P, Lin J.T, Wang H.P. Endoscopic therapeutics for patients with cholangitis caused by the juxtapapillary duodenal diverticulum. Hepatogastroenterology, 2006. Jul-Aug; 53(70): 501-5.
  6. Matthew L., Silvera M.L, Seamon M.J et al. Complications related to endoscopic retrograde cholangiopancreatography: a comprehensive clinical review. J Gastrointestin Liver Dis. 2009 Mar; 18(1):73-82.
  7. Nison Badalov, Scott Terner, John Baillie. The prevention, recognition and treatment of post-ERCP pancreatitis. JOP. J Pancreas (Online) 2009 Mar 9, 10(2):88-97.
  8. Boix J, Lorenzo-Zuniga V, Ananos F, Domenech E, Morillas R.M, Gassull M.A. Inpact of a periampullary duodenal diverticula at endoscopic retrograde cholangiopancreatography: a proposed classification of periampullary duodenal diverticula. Surg Laparosc Endosc Percutan Tech. 2006 Aug;16(4): 208-11.
  9. Cotton P, Leung J. ERCP The fundamentals, 2015: 50-76.
  10. Gromova I. V., Kuzovlev N. F., Urzhumtseva G. A., Grashchenko S. A., Kotovsky A. E. Endoscopic Diagnostic and Therapeutic Interventions in Periampullary Diverticula. Annaly khirurgicheskoi gepatologii. 2000; 5(1): P. 109–113.
  11. Varia D., Dowsett J. E., Hatfield A. R.W. et al. Is duodenal diverticulum a risk factor for sphincterotomy? Gut. 1989. V. 30. P. 939-942
  12. Expert Encyclopedia - Lower GI tract, Bile Duct and Ampullary region, 2013
  13. Balalykin A. S. Anatomy of the terminal segment of the bile duct in the application of carrying endoscopic transpapillar operations. Endoscopicheskaya khirurgiya. – 2007. – № 6. – Р. 3–9.
  14. Aminov I. H., Churkin V. V., Plotnikov E. Y., Podoluzhny V. I., Krasnov K. A., Krasnov O. A. Comparative analysis of methods of drug-induced prevention of post-ERCP pancreatitis. Experimentalnaya i klinicheskaya gastroenterologiya [Experimental and clinical gastroenterology]. – 2012. – № 7. – P. 22–28.
  15. Khan OA, Balaji S, Branagan G. Randomized clinical trial of routine on-table cholangiography during laparoscopic cholecystectomy. Br J Surg. 2011; 98:3: 362–367.

Full text is published :
Kuzmin-Krutetsky M.I., Safoev M.I., Demko A.E., Ulyanov Yu.N., Levina A.S. TECHNICAL ASPECTS OF DIAGNOSTICS AND MANAGEMENT OF CHOLELITHIASIS WITH ADVERSE EVENTS IN PATIENTS WITH PARAVATERIAN DIVERTICULA. Experimental and Clinical Gastroenterology Journal. 2018;152(04):66-70
Read & Download full text

1. FGBNU «Russian Research Center of Surgery named of acad. B. V. Petrovsky” (Moscow, Russian Federation)
2. Endoscopy unit of Municipal Clinical Hospital № 29 named. N. E. Bauman (Moscow, Russian Federation)

Keywords:colorectal cancer, levomenthol solution, colon polyps

Abstract:The purpose of the study: Evaluation of the effectiveness of the using of levomenthol solution in the lumen of the colon to improve visualization of pathological changes during total videocolonoscopy. Materials and methods: We examined 2 groups of patients according to 75 people. The first group was examined with using of levomenthol solution, which was insert in the channel of the endoscope into the lumen of the sigmoid colon during the colonoscopy. The second group was the control, the patients in this group underwent standard colonoscopy. Results: In the group surveyed with the help of drug exposure, it was discovered 56 neoplasias(44 of them size up to 0.5 cm). In the control group identified 28 lesions (11 of them size up to 0.5 cm). In the right part of colon in the two groups was found 30 different histological structure, in the left - 54 neoplasia. The time spent in the videocolonoscopy with the use of levomenthol, amounted to 14.05±3,03 min: time to the dome of the cecum is 5.1 ± 3,8 minutes, during breeding of the endoscope of 8.95 ± 2,67 min. In the control group, these data were 16.06±5,09 min, 6,3 ± 2,6 min and 9,76 ± 4,29 min, respectively. Conclusion: The application of levomenthol solution can significantly increase the efficiency of detecting epithelial tumors of the colon. In terms of levomenthol solution was detected in 4 times more the smallest polyps than standard colonoscopy. Time periods spent in study, was significantly lower in the group of levomenthol, compared to standard colonoscopy.

• References total 13 ⇓ :: .
  1. Vetshev P. S., Stoyko Yu.M., Krylov N. N. Profilaktika, diagnostika i lecheniye novoobrazovaniy tolstoy kishki [Prophylaxis, diagnosis and treatment of colon neoplasms (In Russ.)] RJGHC. 2005; Vol.15. no.1, pp.86.
  2. Gantsev Sh. Kh., Vazhenin A. V., Rakhmatullina I. R., Dudпік V. Yu., Gantsev K. Sh., Ishmuratova R. Sh. Analysis of morbidity, mortality, and survival rates in colonic cancer. Health Care of the Russian Federation. 2005; no.1, pp.21–22
  3. Davydov M. I., Aksel’ Ye. M. Smertnost’ ot zlokachestvennykh novoobrazovaniy [Mortality from malignant neoplasms] JOURNAL of N. N. Blokhin Russian Cancer Research Center RAMS2011; 22(3), pp.93–123.
  4. Zavyalov D., Kashin S. Undetected colorectal lesions. Koloproktologia. 2015; 51(1), pp.32–37.
  5. Ivashkin V. T., Shul’pekova Yu.O., Sekacheva M. I., Nikiforov P. A. Skrining kolorektal’nogo raka [Screening for colorectal cancer] RJGHC. 2002; no4. pp.64–72.
  6. Tsimmerman Ya. S. Colorectal cancer: state-of-the-art. RJGHC. 2012; Vol.22. no4. pp.5–16.
  7. Ahn S.B., Han D. S., Bae J. H., Byun T. J. et al. The Miss Rate for Colorectal Adenoma Determined by Quality-Adjusted, Back-to-Back Colonoscopies // Gut Liver. 2012 Jan; 6(1): 64-70p.
  8. Bond J. H. Colon Polyps and Cancer. // Endoscopy. 2003 Jan. - Vol. 35, N1. - 27-35р.
  9. Dik V.K., Moons L., Siersema P. D. Endoscopic innovations to increase the adenoma detection rate during colonoscopy // World J Gastroenterol. 2014 Mar 7; 20(9): 2200-2211p.
  10. Helwick C. Simple Menthol Spray Can Reveal More Adenomas // Gastroenterology and Endoscopy News. Issue: Oct. 2014. Vol. 65:10.
  11. Inoue K., Dohi O., Gen Y. et al. L-menthol improves adenoma detection rate during colonoscopy: a randomized trial // Endoscopy. 2014 Mar; 46(3): 196-202p.
  12. Rex D. K. Maximizing Detection of Adenomas and Cancers During Colonoscopy. // Am. J Gastroenterology. 2006. - V. 101(12). - 2866-2877р.
  13. Yoshida N., Naito Y., Hirose R., Ogiso K. et al. Prevention of colonic spasm using L-menthol in colonoscopic examination // Int J Colorectal Dis. 2014 May; 29(5): 579-583p.

Full text is published :
Khrustaleva M.V., Khodakovskaya J.А., Godzhello E.A., Dekhtyar M.А. et al. LEVOMENTHOL FOR IMPROVING THE QUALITY OF SCREENING VIDEOCOLONOSCOPY. Experimental and Clinical Gastroenterology Journal. 2018;152(04):71-75
Read & Download full text

1. Moscow research cancer Institute. P. A. Herzen-branch of the national medical research radiological center of the Ministry of health of Russia (Moscow, Russian Federation)

Keywords:chronic inflammation, tumorigenesis, pro-oncogenic mutations, microsatellite instability, Nuclear factor of kappa light gene polypeptide gene enhancer in B cells (NF-κB), MicroRNAs, tumor necrosis factor, miR-155, Helicobacter pylori

Abstract:The interplay between chronic inflammation and tumorigenesis has been widely discussed. Chronic inflammation induces premalignant changes in tissues (tissue metaplasia, atrophic changes, etc.) and promotes local tumor invasion, metastatic spread and tumor progression. Chronic inflammation can also induce changes of the DNA, promoting accumulation of pro-oncogenic mutations, which results in development of specific tumor environment as well as selection of chemo- and radioresistant tumor cells. Suppression of innate and acquired immunity caused by chronic inflammation also promotes tissue changes, increasing the likelihood of tumor development. The synergistic action of all above mentioned factors is implicated in development of multiple malignant neoplasms in a variety of organs. In this article the intricate interplay between chronic inflammation and tumorigenesis in various organs and organ systems is discussed. The understanding of these processes is of greatest importance, especially in gastroenterology, caused by relative prevalence of inflammatory bowel diseases and peptic ulcer disease. Further understanding of these processes can help further improve the diagnostic and treatment approaches to malignant tumors, as well as prevention of inflammation-induced tumor progression.

• References total 21 ⇓ :: .
  1. Dawit K., Wook J. C., Jennifer C., Kristin A., Eckert P. М., Glazer A. L., Bothwell M., and Sweasy J. B. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014 Mar-Apr; 49(2): 116-139.
  2. Coussens L. M., Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26; 420(6917):860-7.
  3. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, Volume 30, Issue 7, 1 July 2009, Pages 1073-1081, https://doi.org/10.1093/carcin/bgp127.
  4. Dizdaroglu M. Oxidatively induced DNA damage: mechanisms, repair and disease.Cancer Lett. 2012 Dec 31; 327(1-2):26-47. Epub 2012 Jan 28.
  5. Kim H. W., Murakami A., Williams M. V., Ohigashi H. Mutagenicity of reactive oxygen and nitrogen species as detected by co-culture of activated inflammatory leukocytes and AS52 cells. Carcinogenesis. 2003 Feb; 24(2):235-41.
  6. McCool K.W., Miyamoto S. Review DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol Rev. 2012 Mar; 246(1):311-26.
  7. Karl S., Pritschow Y., Volcic M., Häcker S., Baumann B., Wiesmüller L., Debatin K. M., Fulda S. Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response. J Cell Mol Med. 2009 Oct; 13(10):4239-56.
  8. Greten F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 2004, vol. 118 (pg. 285-296).
  9. Volcic M., Karl S., Baumann B., Salles D., Daniel P., Fulda S., Wiesmüller L. NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexesNucleic Acids Res. 2012 Jan; 40(1):181-95.
  10. Balkwill F. Tumour necrosis factor and cancer, Nat. Rev. Cancer, 2009, vol. 9 (pg. 361-371)
  11. Harrison M.L. et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose, J. Clin. Oncol., 2007, vol. 25 (pg. 4542-4549).
  12. Mantovani A. et al. Cancer-related inflammation, Nature, 2008, vol. 454 (pg. 436-444).
  13. Sakurai T. et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, Cancer Cell, 2008, vol. 14 (pg. 156-165).
  14. Babar I. A., Czochor J., Steinmetz A., Weidhaas J. B., Glazer P. M., Slack F. J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther. 2011 Nov 15; 12(10):908-14.
  15. Valeri N., Gasparini P., Fabbri M., Braconi C., Veronese A., Lovat F., Adair B., Vannini I., Fanini F., Bottoni A., Costinean S., Sandhu S. K., Nuovo G. J., Alder H., Gafa R., Calore F., Ferracin M., Lanza G., Volinia S., Negrini M., McIlhatton M.A., Amadori D., Fishel R., Croce C. M. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010 Apr 13; 107(15):6982-7.
  16. Krichevsky A. M., Gabriely G. J. MiR-21: a small multi-faceted RNA. Cell Mol Med. 2009 Jan; 13(1):39-53.
  17. Lawrie C. H., Soneji S., Marafioti T., Cooper C. D., Palazzo S., Paterson J. C., Cattan H., Enver T., Mager R., Boultwood J., Wainscoat J. S., Hatton C. S. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007 Sep 1; 121(5):1156-61.
  18. Loeb L. A. et al. DNA polymerases and human disease. Nat. Rev. Genet., 2008, vol. 9 (pg. 594-604).
  19. Mirzaee V. et al. Helicobacter pylori infection and expression of DNA mismatch repair proteins. World J. Gastroenterol., 2008, vol. 14 (pg. 6717-6721).
  20. Brentnall T. A. et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 1996, vol. 56 (pg. 1237-1240).
  21. Kawashima T., Kosaka A., Yan H., Guo Z., Uchiyama R., Fukui R., Kaneko D., Kumagai Y., You D. J., Carreras J., Uematsu S., Jang M. H., Takeuchi O., Kaisho T., Akira S., Miyake K., Tsutsui H., Saito T., Nishimura I., Tsuji N. M. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity. 2013 Jun 27; 38(6):1187-97.

Full text is published :
Saribekyan E.K., Zubovskaia A.G., Shkurnikov M.Yu. CHRONIC INFLAMMATION OF THE GASTROINTESTINAL TRACT AND CARCINOGENESIS. BIOLOGICAL ASPECTS OF THE RELATIONSHIP. Experimental and Clinical Gastroenterology Journal. 2018;152(04):76-82
Read & Download full text

1. NMIC Oncology. N. N. Blokhin” Of the Russian Ministry of Health (Moscow, Russian Federation)

Keywords:gastric cancer, endoscopic ultrasound examination

Abstract:Gastric cancer occupies the 5th place in the structure of total cancer incidence worldwide. In 2015, Russia diagnosed about 35 thousand new cases of rye. Mortality from this disease and its complications remains high. Numerous studies conducted in different countries of the world have shown that the dominant role among all anatomical forms of gastric cancer is played by endophytic tumors (more than 65% of all detected cases), which are the most difficult to diagnose. Even with the latest diagnostic tools, it is often not possible to obtain enough information to clearly speak in favor of the existence of an intra-neoplastic process. Optimization of diagnosis of gastric cancer continues to be one of the important problems of Oncology. The absence of changes in the mucous membrane, usually makes it impossible to determine the boundaries of the standard endoscopic and radiological methods. The possibilities of standard ultrasound examination of the stomach wall, and especially the esophagus wall, are also limited. The most promising in terms of complex diagnosis of intramural and lymphogenic prevalence of tumor process is the use of endoscopic ultrasound.

• References total 24 ⇓ :: .
  1. Kaprin A. D., Starinskiy V. V., Petrova G. V. Osnovnyye pokazateli onkologicheskoy pomoshchi naseleniyu. Sostoyaniye onkologicheskoy pomoshchi naseleniyu Rossii v 2015 godu. [The main indicators of oncological care for the population. The state of oncological assistance to the population of Russia in 2015.] Moscow: MNIOI them. P. A. Herzen is a branch of the Federal Medical and Biological Center NIIRTs of the Russian Ministry of Health. Publ., 2016, 279 p.
  2. Davydova M. I., Aksel’ E. M. Zlokachestvennyye novoobrazovaniya v Rossii i stranakh SNG v 2001 godu. [Malignant neoplasms in Russia and the CIS countries in 2001] GU RONTS them. NN Blokhin RAMS. Moscow, Medical News Agency, 2003, 95–97 p, 223–224 p.
  3. Davydov M. I. Printsipy khirurgicheskogo lecheniya zlokachestvennykh opukholei v torakoabdominal’noi klinike. [Principles of surgical treatment of malignant tumors in the thoracoabdominal clinic] Vopr onkol 2002; 4–5: 468–479.
  4. Ji Yeong An, Ho Geun Youn, Min Gew Choi et al. The difficult choice between total and proximal gastrectomy in proximal early gastric cance. Am. J. Surg. – 2008. – N196. – P. 587–591
  5. Miyazono F., Natsugoe S., Ishigami S. et al. Histological differences in the invasion of the advanced esophageal and gastric carcinoma beyond thе esophago-gastric junction // Gastric Cancer. – 2002. – Vol. 3. – P. 45–49
  6. Davydov M. I., Ter-Ovanesov M.D., Makhovsky V. V. The state of the problem and ways to optimize the tactics of surgical treatment of patients with stomach cancer of the older age group. Surgery. 2008, no.10, pp. 73–79
  7. Grigor’ev GYa, Yakovenko EP. [Stomach cancer]. Diagnosis and treatment of diseases of the digestive. Sankt-Peterburg. 1997, 396–402 p. (In Russia)
  8. Portnoy L. M., Dibirov M. P. Luchevaya diagnostika endofitnogo raka zheludka. [Radiation diagnosis of endophytic gastric cancer.] Medicine Publ., 1993. 3–4, 9–18, 203–230 p.
  9. Kaneko K., Kondo H., et al. Early gastric stump cancer following distal gastrectomy. Gut.-1998.V.43.-P.342–344.
  10. Samtsov E. N., Luneva S. V., Velichko S. A. Vozmozhnosti kompleksnoy ekhografii v otsenke vnutri- stenochnogo rasprostraneniya raka zheludka [The possibilities of complex echography in assessing the intra-wall distribution of gastric cancer] Sibirskiy onkologicheskiy zhurnal – Siberian Cancer Journal. 2006, no.3, pp. 64–67
  11. Tsuda Y. Endoscopic observation of gastric lesions with a dye7spraying technique// Endoscopic Gastroenterology – 1987. – Vol. 9. – P. 189–195/
  12. Yoshida S., Yamaguchi H., Saito D., Kido M. Endoscopic diagnosis: latest trends// Gastric Cancer/ Nishi M., Ichikawa H. et al. (eds.). – Springer7Verlag, 1993. – P. 246–262
  13. Turkin I. N. Strategiya khirurgii raka zheludka. Diss. dokt. med. nauk. [The strategy of stomach cancer surgery. Doct. Diss.] Moscow, 2013. 391 p.
  14. Turkin I. N., Ibraev M. A., Davydov.M.M., Perfiliev I. B. Abdominomediastinal access posibilities with use of the circular stapler in patients with stomach cancer with high transition to the gullet. Journal of N. N. Blokhin Russian Cancer Research Center 2015; 26(3):39–49.
  15. Zherlov G. K., Sokolov S. A., Rudaya N. S. et al. Rukovodstvo po ul’trazvukovoy diagnostike zabolevaniy pishchevoda, zheludka i dvenadtsatiperstnoy kishki [Guide to ultrasound diagnosis of diseases of the esophagus, stomach and duodenum]. Novosibirsk: Science Publ., 2005. 208 p.
  16. Starkov Yu.G., Solodinina E. N., Shishi K. V. Development of diagnostic technologies in endoscopy and presentday potential for diagnosing gastrointestinal tract neoplasms. Pacific Medical Journal, 2009, no.2, pp. 35–39
  17. Korneyev K. A., Zhitov D. I., Laletin V. G., Kukarin V. V. Vozmozhnosti zondovoy endoskopicheskoy ul’trasonografii v diagnostike opukholey pishchevoda [Possibilities of probe endoscopic ultrasonography in the diagnosis of esophageal tumors]. Siberian journal of oncology. 2010, no.1, pp.60
  18. Davydov M. M., Turkin I. N., et al. One-step esophago-gastrec tomies in oncology. Vestnik Moskovskogo Onkologicheskogo Obshchestva – Bulletin of the Moscow Cancer Society 2011, 574(1), pp.2–7
  19. Kruglova I. I., Kozlov S. V., Malikhova O. A. Endosonograficheskaya diagnostika epitelial’nykh i neepitelial’nykh zlokachestvennykh novoobrazovaniy zheludka [Endosonographic diagnosis of epithelial and non-epithelial malignant neoplasms of the stomach]. Samarskiy meditsinskiy zhurnal – Samara Medical Journal 2008;41(1):57–60
  20. Kruglova I. I., Morozova M. A. Opyt endoskopicheskogo monitoringa bol’nykh so zlokachestvennymi novoobrazovaniyami zheludochno-kishechnogo trakta posle ikh radikal’nogo lecheniya [Experience of endoscopic monitoring of patients with malignant neoplasms of the gastrointestinal tract after their radical treatment]. Sbornik tezisov konferentsii «Dni RONTS im. N. G. Blokhina v Samarskoy oblasti» Conference abstracts «Days of the RCRC. N. G. Blokhin in the Samara region”, 2005, pp. 163–164
  21. Scherbakov A. M., Avanesyan A. A. Endoscopic ultra- sound sonography (EUS) Problems in oncology. 2009;55(6): 679–683.
  22. Kruglova I. I. Optimizatsiya utochnyayushchey diagnostiki raka zheludka s ispol’zovaniyem endosonografii. Diss. kand. med. nauk. [Optimization of the clarifying diagnosis of stomach cancer using endosonography. Cand. Diss.] Kazan, 2009
  23. Diomidova V. N. Transabdominal’naya sonografiya v diagnostike predrakovoy i opukholevoy patologiy zheludka Diss. dokt. med. nauk. [Transabdominal sonography in the diagnosis of precancerous and tumor pathologies of the stomach. Doct. Diss.] Kazan, 2009
  24. Shavlikova L. A., Sukonko T. F. Novosti luchevoy diagnostiki [News of Beam Diagnostics] Moscow, 2001. 37–39 p.

Full text is published :
Belyaeva T.V., Ibraev M.A., Kuvshinov Yu.P., Melikhova O.A. THE ROLE OF COMPLEX ENDOSCOPIC AND ENDOSONOGRAPHIC STUDIES IN THE DIAGNOSIS OF PROXIMAL GASTRIC CANCER. Experimental and Clinical Gastroenterology Journal. 2018;152(04):83-88
Read & Download full text

1. North-Western state medical University named after I. I. Mechnikov (St. Petersburg, Russian Federation)
2. Federal State Budgetary Educational Institution of Higher Education “Yaroslav-the-Wise Novgorod State University” (Novgorod, Russian Federation)
3. St Petersburg University (St. Petersburg, Russian Federation)
4. Institute of Toxicology of the Federal Medical and Biological Agency (St. Petersburg, Russian Federation)

Keywords:chronic liver disease, intrahepatic cholestasis, Remaxol, viral hepatitis, metabolic hepatitis, toxic hepatitis, autoimmune hepatitis, hepatoprotective effect, anticholestatic action

Abstract:Aim. To investigate the impact of infusion therapy with Remaxol® on liver function in patients with intrahepatic cholestasis in chronic liver diseases (metabolic, drug, alcoholic hepatitis, chronic hepatitis B, C, autoimmune hepatitis, primary biliary cirrhosis, cross autoimmune syndrome). Subjects and methods. 102 patients aged 25 to 80 years, with intrahepatic cholestasis syndrome with chronic liver diseases different etiology were examined. Patients of the main group (n = 68) in the complex therapy received an infusion hepatoprotector Remaxol® daily intravenously drip 400.0 ml once a day for 11 days. Patients of the comparison group (n = 34) in the complex therapy received lyophilizate to prepare a solution for intravenous and intramuscular administration of ademetionine 400 mg diluted in the original solvent. Results. Infusion therapy with Remaxol® for chronic liver diseases of various etiologies (viral, metabolic, toxic, autoimmune), with intrahepatic cholestasis promotes: regression of the main clinical syndromes (pain abdominal from 68% to 25%, dyspeptic, 80% to 26% asthenic from 92% to 52% (p <0.05), cholestatic from 100% to 24% (p <0.05). A statistically significant difference in the dynamics of cholestasis was demonstrated by the change in the GGT value between the groups studied: the relative values of reduction in GGT levels in the patients of the main group were 38% compared to 19% in the comparison group patients (p <0.05). In the patients of the main group, the level of total cholesterol was reduced in dynamics from 10,10 ± 1,20 to 6,23 ± 0,31 mmol/l (p <0,001); improvement of protein-synthetic liver function; an increase in the absolute number of lymphocytes from 1.05 ± 0.08 x 109/l to 1.53 ± 0.06 x 109/l, (p <0.05). Conclusion. The effectiveness of Remaxol® in patients with intrahepatic cholestasis indicates the role of hepatoprotective, anticholestatic, cytoprotective effect of antioxidant therapy in restoring the functional status of the liver, immunoreactivity cells, as well as the presence of a lipid-regulating effect of the drug.

• References total 34 ⇓ :: .
  1. Babak O.YA. Cholestasis syndrome: what each doctor needs to know. Ukrainskij terapevticheskij zhurnal. 2005;3:4–22
  2. Diseases of the liver and biliary tract: A guide for doctors/ pod red. V. T. Ivashkina. – 2-e izd. Moscow, OOO Izd. Dom “Vesti” Publ., 2005. P. 586
  3. Bueverov A. O. Medicinal liver damage as a cause of intrahepatic cholestasis. Klinicheskie perspektivy gastroehnterologii, gepatologii. 2005;6:2–6
  4. Golovanova E. V. Diagnostika i lechenie vnutripechenochnogo holestaza pri hronicheskih zabolevaniyah pecheni Dokt, Diss. [Diagnosis and treatment of intrahepatic cholestasis in chronic liver diseases Doct. Diss.] Moscow, 2008 236 p.
  5. Zvyaginceva T.D., CHernobaj A. I. Cholestatic diseases of the liver: modern approaches to diagnosis and treatment. Novosti mediciny i farmacii. 2006;5:25–26.
  6. Ivashkin V.T., SHirokova E.N., Maevskaya M. V., Pavlov CH.S., SHifrin O. S. Clinical recommendations for the diagnosis and treatment of cholestasis. Moscow, 2013. p. 39
  7. Kan V. K. Cholestasis: new in pathogenesis, diagnosis and treatment. Ros. zhurn. gastroehnterolog., gepatol., koloproktol. 1997;7(3):25–29
  8. Kovalenko A.L., Petrov A. Yu., Suhanov D. S., Savateeva T. N. et al. Remaxol – a preparation for the restoration of the antioxidant defense system for liver damage with cyclophosphamide in an experiment. Eksperimental'naya i klinicheskaya farmakologiya 2011;1:32–35
  9. Kozlov V. K. Sepsis: Etiology, immunopathogenesis, the concept of modern immunotherapy. Saint Petersburg, Dialekt. Publ. 2008. p.295
  10. Minushkin O. N. Treatment of the main manifestations of liver disease. Klinicheskaya farmakologiya i terapiya. 1996;1:4–8
  11. Nikitin I.G., Storozhakov G. I. Medicinal lesions of the liver. Diseases of the liver and biliary tract: A guide for doctors. Ed. V. T. Ivashkin. Мoscow, “М–Vesti” Publ. 2002. p.122–131
  12. Podymova S. D. Diseases of the liver M.: Medicina Publ. 2005. p.768
  13. Radchenko V.G., SHabrov A.V., Zinov'eva E. N. Diseases of the liver and bile ducts: a guide for doctors. SPb: SpecLit 2011: 241–269]
  14. Reshetnyak V. I. Mekhanizm razvitiya vnutripechenochnogo holestaza i lechenie bol'nyh pervichnym biliarnym cirrozom pecheni Dokt. Diss. [Mechanism of development of intrahepatic cholestasis and treatment of patients with primary biliary cirrhosis. Doct. Diss.] Moscow 1996. 280 p.
  15. Romancov M.G., Suhanov D. S., Petrov A.Yu. The use of substrates for energy metabolism in chronic liver damage for the correction of metabolic disorders (experimental and clinical studies). Fundamental. issled. 2011;3:131–142.
  16. Smirnova N.G., CHefu S.G., Kovalenko A. L., Grashin R.A The state of free radical oxidation and antioxidant protection in experimental cholestasis. Surgery. Journal of them. N. I. Pirogov. 2011;3:50–55.
  17. Sologub T. V., Goryacheva L. G., Suhanov D. S. Hepatoprotective activity of remaxol in chronic liver lesions. Klinicheskaya medicina. 2010; 1: 62–66.
  18. Sologub T. V., Goryacheva L. G., Suhanov D. S., Romancov M. G. A study of pharmacotherapeutic efficacy, safety with an assessment of the risk of adverse outcomes, the inclusion of remaxol in the therapy of chronic liver lesions. Vestn. SPbGMA im. I. I. Mechnikova. 2009;2:112–116.
  19. Ctel'mah V.V., Kozlov V. K., Radchenko V. G., Nekrasova A. S. Pathogenetic therapy of metabolic syndrome at the stage of organ damage. Klin med 2012;6:66–70
  20. Ctel'mah V.V., Radchenko V. G., Kozlov V. K. Metabolic correctors on the basis of succinic acid as a means of pathogenetic therapy for chronic viral hepatitis. Terapevticheskij arhiv. 2011;2:67–71.
  21. Stel'mah V.V., Kozlov V. K., Samusenko I. A. Morphofunctional state of resident liver macrophages in chronic viral hepatitis is the point of application of succinate-containing drugs. Medicinskij alfavit. Prakticheskaya gastroehnterologiya. 2017;40(4):62–68.
  22. Suhanov D.S., Ivanov A. K., Romancov M. G., Kovalenko A. L. Treatment of hepatotoxic complications of anti-tuberculosis therapy with succinate-containing drugs. Ros med zhurnal. 2012;6:22–25.
  23. Suhanov D.S., Petrov A.YU., Kovalenko A. L., Romancov M. G. Induction of S-adenosyl-L-methionine in hepatocytes during pharmacotherapy of toxic and medicinal liver lesions in the experiment. Eksperimental'naya i klinicheskaya farmakologiya. 2011;10:34–38
  24. Ushkalova E. A. Medicinal lesions of the liver. Vrach. 2007;3:22–26
  25. Shilov V. V., SHikalova I. A., Vasil'ev S. A. Features of pharmacological correction of toxic liver damage in patients with alcohol dependence and severe forms of ethanol poisoning. Zhurn nevrol i psihiatr. 2012;1:45–48
  26. Catalino F., Scarponi S., Cesa F. et al. Efficacy and safety of intravenosus S-denosyl-L–Methionine therapy in the management of intrahepatic cholestasis of pregnancy // Drug Invest. 1992. Vol. 4. Suppl. 4. P. 78–82.
  27. Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010; 139:1481–96.
  28. Karlsen T. Schrumph E., Boberg K. M. Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2010; 24:655–666.
  29. Lammert C, Juran BD, Schlicht E, et al. Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. J Gastroenterol. 2014 Oct;49(10):1414–20.
  30. Leushner M., Maier K.-M., Schlichting J. et al. Oral budesonide and ursodeoxycholic acid treatment of primary biliary cirrhosis: results of a prospective double-blind trial// Gastroenterology. – 1999. – Vol. 117. – P. 918–925.
  31. Lucena MI, Garcia-Martin E., Andrade RG, et al. Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 2010; 52:303–312.
  32. Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004 Feb;8(1):67–81
  33. Russman S., Jetter A., Kullak-Ublic G.A. Pharmacogenetics of drug-induced liver injury. Hepatology 2010; 52: 748–761.
  34. Trauner M, Fickert P, Halilbasic E, Moustafa T. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Klin Wochenschr 2008; 158:542–548.

Full text is published :
Stelmakh V.V., Kovalenko A.L., Kozlov V.K. EFFICIENCY OF THE PREPARATION “REMAXOL, SOLUTION FOR INFUSIONS” IN THE THERAPY OF PATIENTS WITH THE SYNDROME OF INTRAUPECULAR CHOLESTASIS IN CHRONIC DIFFUSION DISEASES OF THE LIVER. Experimental and Clinical Gastroenterology Journal. 2018;152(04):89-98
Read & Download full text

1. Leningrad regional clinical hospital (St. Petersburg, Russian Federation)
2. SSC LM them. O. K. Skobelkin FMBA of Russia (Moscow, Russian Federation)
3. Peoples friendship University of Russia (Moscow, Russian Federation)

Keywords: laterally spreading tumor, endoscopic mucosal resection, control of the removal of the focus of residual tumor tissue, ZOOM, argon-plasma coagulation

Abstract:The removal of the laterally spreading tumor is a radical method of its treatment; it is necessary to control the completeness of LST removal using ZOOM and destruction of residual tumor tissue by argon-plasma coagulation to prevent recurrence of the tumor.

• References total 6 ⇓ :: .
  1. Sakamoto T, Saito Y, Nakamura F, Abe S, Takamaru H, Sekiguchi M, Yamada M, Nakajima T, Matsuda T, Yamagishi H, Kato H. Short-term outcomes following endoscopic submucosal dissection of large protruding colorectal neoplasms. Endoscopy. 2017 Dec 13. doi: 10.1055/s-0043-123578.
  2. Mizushima T, Kato M, Iwanaga I, Sato F, Kubo K, Ehira N, Uebayashi M, Ono S, Nakagawa M, Mabe K, Shimizu Y, Sakamoto N. Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors. Surg Endosc. 2015 Jan;29(1):133-9. doi: 10.1007/s00464-014-3665-9.
  3. Князев М.В., Дуванский В. А. Эндоскопическая резекция слизистой с диссекцией подслизистого слоя - 20 лет спустя (обзор зарубежной литературы) // Экспериментальная и клиническая гастроэнтерология. -2015. № 4 (116). С. 53-58.
  4. Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, Fukuzawa M, Kobayashi N, Nasu J, Michida T, Yoshida S, Ikehara H, Otake Y, Nakajima T, Matsuda T, Saito D. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010 Dec;72(6):1217-25. doi: 10.1016/j.gie.2010.08.004
  5. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993; 25:455-461
  6. Nakajima T, Saito Y, Tanaka S, Iishi H, Kudo S.E, Ikematsu H, Igarashi M, Saitoh Y, Inoue Y, Kobayashi K, Hisasbe T, Matsuda T, Ishikawa H, Sugihara K Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc. 2013 Sep;27(9):3262-70. doi: 10.1007/s00464-013-2903-x

Full text is published :
Chernykh D.A., Myaukina L.M., Filin A.A., Duvanskiy V.A. CONTROL OF THE COMPLETENESS REMOVAL LATERALLY SPREADING TUMOR (LST). Experimental and Clinical Gastroenterology Journal. 2018;152(04):99-100
Read & Download full text

1. The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery» (Moscow, Russian Federation)

Keywords: inflammatory myofibroblastic tumor, endoscopic ultrasonography, common bile duct (CBD), ERCP, EPST

Abstract:Aim: The inflammatory myofibroblastic tumor (IMT) is rare and has an intermediate malignancy in terms of local invasiveness. There are pulmonary and extrapulmonary forms that are rare to be come across. Among extrapulmonary forms, biliary lesion occurs in isolated instances. Due to the rarity of the disease, we provide our own clinical observation. In a 35-year-old patient various instrumental methods showed the formation in the distal common bile duct (CBD), which manifested the painless form of jaundice. The presence of tissue mass in the distal CBD is often associated with malignant neoplasms. One of the informative instrumental techniques turned out to be endosonography and endoscopic retrograde therapeutic and diagnostic interventions on extrahepatic bile ducts with biopsy sampling. Due to the rarity of the disease and the precaution regarding the malignant origin of the neoplasm in the distal CBD, the patient underwent a surgery. Histological and immunohistochemical data confirmed the inflammatory myofibroblastic tumor.

• References total 27 ⇓ :: .
  1. Dubova E. А., Pavlov K. А., Frank G. А., Shhegolev А. I. Vospalitel’naya miofibroblasticheskaya opukhol’ pecheni [Inflammatorymiofibroblastiсliver tumor]. Аrkh patol 2009; 3:25–28. (In Russian)
  2. Frank G. А. Problemy morfologicheskoj klassifikatsii i diagnostiki opukholej myagkikh tkanej [Problems of morphological classification and diagnosis of soft tissue tumors]. Prakticheskaya onkologiya 2004; 5: 4: 231–236. (In Russian)
  3. Coffin C.M., Hornick J. L., Fletcher C. D. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007; 31: 4: 509–520.
  4. Popov S. D., Il’ina N. A. Inflammatory myofibroblasts tumor of the lung: Problems in differential diagnosis. Journal of radiology and nuclear medicine. 2013; 6: 38–43
  5. Patnana M., Sevrukov А., Elsayes K. M. et al. Inflammatory Pseudotumor: The Great Mimicker. Am J Roentgenol 2012; 198: 217–227.
  6. Pack G.T., Baker H. W. Total right hepatic lobectomy: report of a case. Ann Surg 1953; 138: 53–58.
  7. Lopez-Tomassetti Fernandez E. M., Luis H. D., Malagon A. M., Gonzalez I. A., Pallares A. C. Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases. World J Gastroenterol. 2006 Jun 28; 12 (24): 3938–3943.
  8. Arpacı E., Yetişyiğit T., Ulaş A. et al. A case of intraabdominal myofibroblastic tumor with aggressive behavior. Turkish Journal of Oncology 2010; 25: 1: 28–32.
  9. Gleason B.C., Hornick J. L. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008; 61: 428–437.
  10. Kim K., Park C., Lee J. et al. Inflammatory myofibroblastic tumor of the stomach with peritoneal dissemination in a young adult: imaging findings. Abdom Imaging 2004; 29: 9–11.
  11. Hosler G.A., Steinberg D. M., Sheth S. et al. Inflammatory pseudotumor: a diagnostic dilemma in cytopathology. Diagnostic Cytopathology 2004; 4: 267–270.
  12. Shi H., Wei L., Sun L., Guo A. Primary gastric inflammatory myofibroblastic tumor: A clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract 2010; 206: 5: 287–291.
  13. Butrynski J.E., D’Adamo D.R., Hornick J. L. et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363: 18: 1727–1733.
  14. Cook J.R., Dehner L. P., Collins M. H., Ma Z., Morris S. W., Coffin C. M. et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001; 25: 1364–1371.
  15. Kim B.S., Joo S. H., Kim G. Y., Joo K. R. Aggressive hilar inflammatory myofibroblastic tumor with hilar bile duct carcinoma in situ. J Korean Surg Soc. 2011 Dec; 81 Suppl 1: S59–63. doi: 10.4174/jkss.2011.81.Suppl1.S59. Epub 2011 Nov 25.
  16. Martín Malagón A., López-Tomassetti Fernández E., Arteaga González I., Carrillo Pallarés A., Díaz Luis H. Inflammatory myofibroblastic tumor of the distal bile duct associated with lymphoplasmacytic sclerosing pancreatitis. Case report and review of the literature. Pancreatology. 2006; 6 (1–2): 145–54.
  17. Rosenbaum L., Fekrazad M. H., Rabinowitz I., Vasef M. A. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop. 2009; 2: 127–131.
  18. Dehner L.P., Coffin C. M. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol. 1998 May; 15 (2): 161–173.
  19. Sim A, Lee MW, Nguyen GK. Inflammatory myofibroblastic tumour of the pancreas. Can J Surg.2008; 51: E23-E24.
  20. Pungpapong S., Geiger X. J., Raimondo M. Inflammatory myofibroblastic tumor presenting as a pancreatic mass: a case report and review of the literature. JOP. 2004; 5: 360–367.
  21. Ashcroft M.W., Ng C. S., Frost R. A., Freeman A. H. Biliary inflammatory pseudotumour: report of two cases and review of the literature. Clin Radiol. 2009; 64: 449–455.
  22. Büyükyavuz I., Karnak I., Haliloglu M., Senocak M. E. Inflammatory myofibroblastic tumour of the extrahepatic bile ducts: an unusual cause of obstructive jaundice in children. Eur J Pediatr Surg. 2003 Dec; 13 (6): 421–4.
  23. Kwak J.W., Paik C. N., Jung S. H., Chang U. I., Lee K. M., Chung W. C., Yoo J. Y., Yang J. M. An inflammatory myofibroblastic tumor of the ampulla of vater successfully managed with endoscopic papillectomy: report of a case. Gut Liver. 2010 Sep; 4(3): 419–22.
  24. Stuckmann G., Flury R., Heinz W., Strunk H. Inflammatory myofibroblastic tumour (so-called pseudotumour) of the hepatobiliary system. Ultraschall Med. 2004 Sep; 25(5): 373–6.
  25. Rastogi A., Bihari C., Gupta N., Deka P., Kumar A., Negi S. S., Arora A. Hilar Inflammatory Pseudotumour with Hepatic Artery Atheroma-mimicker of Klatskin Tumour. Indian J Surg Oncol. 2015 Mar; 6(1): 86–89.
  26. Venkataraman S., Semelka R. C., Braga L., Danet I. M., Woosley J. T. Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology. 2003; 227: 758–763.
  27. Donner L.R., Trompler R. A., White R. R. 4th Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol. 1996; 27: 1095–1098.

Full text is published :
Godzhello E. A., Khrustaleva M. V., Bulganina N. A., Dekhtyar M. A. ENDOSCOPIC DIAGNOSIS OF THE DISTAL COMMON BILE DUCT MYOFIBROBLASTIC TUMOR IN THE35-YEAR-OLD PATIENT. Experimental and Clinical Gastroenterology Journal. 2018;152(04):101-106
Read & Download full text

1. Fgbu “Institute of surgery. A. V. Vishnevsky” (Moscow, Russian Federation)

Keywords: ERCP, endoscopic treatment, iatrogenic strictures, posttraumatic strictures, strictures of bile ducts, stenting, plastic stents, complications

Abstract:Introduction. Iatrogenic bile duct injury continues to be one of the most important clinical problems in surgery. Due to the development of non-surgical ways of treatment, bile duct injury is mainly managed endoscopiccally. Materials and methods. 53 y. o. female patient was admitted in April of 2015. According to the anamnesis - laparoscopic cholecystectomy in February 2015, complicated with the injury of the right hepatic duct (clipped and cut). MRCP- right hepatic duct is blocked by the confluence. 27.04.2015 ERCP, ERS, ballon dilatation of the stump and placement of the 7Fr stent in the right hepatic duct. Results. Until May 2016 the patient had 3 restenting operations on the right hepatic duct with the bigger stent each time (8.5, 10 Fr). The last ERCP was finished with the removal of the plastic stent. During the contrast study the diameter of the duct in the structure area was 4 mm. The patient is monitored with no relapse for 1 year and 6 months. Conclusions. Minimally invasive endoscopic treatment of iatrogenic bile duct injuries with a step by step stenting is more preemptive then open reconstruction surgical procedures.

• References total 11 ⇓ :: .
  1. Walsh R.M., Henderson J. M., Vogt D. P., Brown N. Long-term outcome of biliary reconstruction for bile duct injuries from laparoscopic cholecystectomies. // Surgery, 2007. 142(4): p. 450-6; discussion 456-7
  2. Reuver P.R., Sprangers M. A., Rauws E. A. et al. Impact of bile duct injury after laparoscopic cholecystectomy on quality of life: a longitudinal study after multidisciplinary treatment. // Endoscopy, 2008. 40(8): p. 637-43.
  3. Gal’perin E.I., Kuzovlev N. F., Karagyulyan S. R. Rubtsovyye striktury zhelchnykh protokov [Cicatricial stricture of the bile duct] Moscow, Medicine Publ., 1982. 240 p.
  4. Borisov A. E. Rukovodstvo po khirurgii pecheni i zhelchevyvodyashchikh putey [Руководство по хирургии печени и желчевыводящих путей]. St. Petersburg: Scythia, 2003. 488 p.
  5. Milonov O. B., Movchun A. A. Vosstanovitel’nyye i rekonstruktivnyye operatsii na zhelchnykh protokakh. Rekonstruktivnaya khirurgiya i transplantologiya organov [Restorative and reconstructive operations on the bile ducts. Reconstructive surgery and organ transplantation.] Mocsow, 1973. 115–116 p.
  6. Nechay A. I., Novikova K. V. Prichiny i predraspolagayushchiye obstoyatel’stva sluchaynykh povrezhdeniy zhelchnykh protokov pri kholetsistoektomii i rezektsii zheludka [Causes and predisposing circumstances of accidental bile duct damage in cholecystectomy and gastrectomy]. Vestnik khirurgii – Bulletin surgery, 1991, no.1, pp.15–21 (in Russian).
  7. Petrovskiy B. V., Milonov O. B., Smirnov V. A. Rekonstruktivnaya khirurgiya pri porazhenii vnepechenochnykh zhelchnykh protokov [Reconstructive surgery for lesion of extrahepatic bile ducts]. Moscow, 1980. 304 p.
  8. Savel’ev V.S., Moguchev V. M., Filimonov M. I. 1971. Damage to the main biliary ducts during cholecystectomy. Khirurgiya. [Surgery] 5: 47–51. (in Russian).
  9. Shalimov A. A. et al. Khirurgiya pecheni i zhelchnykh protokov [Surgery of the liver and bile ducts]. Kiev, Health Publ., 1975. 407 p.
  10. Thompson C.M., Saad N. E., Quazi R. R. et al. Management of iatrogenic bile duct injuries: role of the interventional radiologist. // Radiographics, 2013. 33(1): p. 117–34.
  11. Adler DG, Papachristou GI, Taylor LJ, McVay T, Birch M, Francis G, Zabolotsky A, Jaique SN, Hayat U, Zhan T, Das R, Slivka A, Rabinovitz M, Munigala S, SiddiquiAA. Clinical outcomes in patients with bile leaks treated via ERCP: a large multicenter study. Gastrointest Endosc.2016 Aug 26. pii: S0016–5107(16)30524–7.

Full text is published :
Starkov Y.G., Viborny M.I., Dzhantuhanova S.V., Andreytseva O.I., Hon E.I. ENDOSCOPIC SURGICAL TREATMENT OF INJURIES OF THE RIGHT LOBAR BILE DUCT IN A PATIENT OF 53 YEARS. Experimental and Clinical Gastroenterology Journal. 2018;152(04):107-110
Read & Download full text

1. Federal state budgetary institution of science Institute of history of natural science and technology. S. I. Vavilov of the Russian Academy of Sciences (Moscow, Russian Federation)

Abstract:In the autumn of 1908, the Assembly of the Karolinska Nobel Institute in Stockholm awarded the prize in physiology and medicine to two of the most prominent exponents of an alternative view of the nature of immunity - Russian biologist Ilya Ilyich Mechnikov. Deputy Director of the Pasteur Institute in Paris, and German bacteriologist Paul Ehrlich - Director of the Royal Institute of experimental medicine and the Institute of chemotherapy. George Speer in Frankfurt am Main. Below is a translation of the text of the invitation of the Nobel Committee addressed to the Russian winner of the prize - I. I. Mechnikov and signed the Executive administrator of the Nobel Fund, count K. A. Morner

• References total 19 ⇓ :: .
  1. В июне 1909 года в Стокгольме перед Нобелевским Комитетом И. И. Мечников прочел лекцию «Современное положение вопроса об иммунитете при заразных болезнях» (на французском языке). Черновик лекции хранится в Фонде И. И. Мечникова в Архиве РАН // Фонд 584. Опись 16. Лист 86
  2. Блох А. М. Архивы Нобелевского фонда приоткрываются: Иван Павлов и Илья Мечников // Природа, 2001. -№ 7. -С.3-9
  3. Обращение в Нобелевский Комитет Н. Я. Чистовича в 1904 году, 2 стр. // Архив РАН. Фонд 584. Опись 2. Лист 146
  4. Блох А. М. Архивы Нобелевского фонда приоткрываются: Иван Павлов и Илья Мечников // Природа, 2001. -№ 7. -С. 8
  5. Блох А. М. Архивы Нобелевского фонда приоткрываются: Иван Павлов и Илья Мечников // Природа, 2001. -№ 7. -С. 9
  6. Петров Р. В., Ульянкина Т. И. И. И. Мечников: Открытие иммунной системы // Иммунология. 1995. № 3. С. 3-6
  7. Ульянкина Т. И. Зарождение иммунологии. М. Наука, 1994. С. 97
  8. Мечников И. И. Академическое собрание сочинений. Том 5. 1954. С. 16-20; Т. 6. 1952. С. 3-21
  9. Линдеман В. К. Цитолизины как причина токсических нефритов. М.: Бархударян, 1901
  10. Мечников И. И. Академическое собрание сочинений. Том 6. 1953.С.220, 223, 224
  11. Ульянкина Т. И. Зарождение иммунологии. М.: Наука, 1994. С. 121
  12. Ульянкина Т. И. Зарождение иммунологии. М.: Наука, 1994. С. 128-129
  13. Bordet J. Les leucocytes et les proprietes actives du serum chez les vaccines //Ann. Inst. Pasteur, 1895. Vol. 9. P. 462-506
  14. Deutch L. Contribution a l’etude de l’origine des anticorps typhiques //Ann. Inst. Pasteur, 1899. Vol. 13. P. 689-727
  15. Marquardt M. Paul Ehrich. London: Heinemann, 1949; Dale H. Paul Ehrlich // BMJ, 1954, Vol. 1. P. 659-663
  16. Ehrlich P. Collected papers of Paul Ehrlich: 4 vol. /Ed. E. Himmelweit. L. - N.Y.: Pergamon Press, 1956-1960. Turk J. L. Paul Ehrlich - the dawn of immunology //Journal of the Royal Society of Medicine, 1994. Vol. 87, June, P. 313-315
  17. Ульянкина Т. И. Зарождение иммунологии. М.: Наука, 1994. С. 156-182
  18. Ульянкина Т. И. Пауль Эрлих и его графические модели (К 100-летию теории боковых цепей) // Врач, 1997. № 12. Декабрь. С. 42-45
  19. Ehrlich P. Collected papers of Paul Ehrlich: 4 vol. /Ed. E. Himmelweit. L. - N.Y.: Pergamon Press, 1956-1960

Full text is published :
Ulyankina T. I. TO THE 110TH ANNIVERSARY OF THE NOBEL PRIZE IN PHYSIOLOGY AND MEDICINE: I. I. MECHNIKOV (RUSSIA) AND P. EHRLICH (GERMANY). Experimental and Clinical Gastroenterology Journal. 2018;152(04):111-118
Read & Download full text

1. Medical Center of S. V. Nudelman (Yekaterinburg, Russian Federation)

Abstract:The First Eurasian Forum on Endoscopy and Gastroenterology was held at the Presidential Center "Yeltsin Center" on August 17-18, 2017 in Yekaterinburg. For the first time, the Forum brought together endoscopists, gastroenterologists, surgeons, hospital epidemiologists, endoscopic and operating nurses. The forum was attended by over 450 specialists from the Urals Federal District and other regions of Russia and abroad.

Full text is published :
Ivantsova M.A. I EURASIAN FORUM ON ENDOSCOPY AND GASTROENTEROLOGY «URALENDO 2017» AUGUST 17-18, 2017, YEKATERINBURG. Experimental and Clinical Gastroenterology Journal. 2018;152(04):119-120
Read & Download full text

1. Chuvash State University named by I. N. Ulyanov (Cheboksary, Russian Federation)

Abstract:The work of the Plenum in Chuvashia was organized in the framework of the scientific and educational project “The School of Therapeutic Patients in Memory of Professor V. N. Saperov. The possibility of saving life in a rational clinical practice" and dedicated to the actual topic of the influence of alcohol on human health and life expectancy. The On-site Plenary Session was organised by the Ministry of Health of the Chuvash Republic, GAU DPO “Institute for Advanced Medical Studies” of the Ministry of Health of the Chuvash Republic, Federal State Budget Educational Institution of Higher Medical Education “Chuvash State University named after I. N. Ulyanov,” Chuvash regional department of the All-Russian public organization "Russian Scientific Medical Society of Physicians", BU "Republican Clinical Hospital"

Full text is published :
Tarasova L. V., Tsyganova Yu.V. REPORT ON THE CONDUCT OF THE EXTENTING PLENARY OF THE NOGR - INTERREGIONAL VOLGA CONFERENCE “THE INFLUENCE OF ALCOHOL ON HUMAN HEALTH AND THE LENGTH OF LIFE” (MARCH, 30-31, 2018 CHEBOKSARY). Experimental and Clinical Gastroenterology Journal. 2018;152(04):121-123
Read & Download full text